SpaceX a Charter Communications jednaly o partnerství na nabídce mobilních služeb pro spotřebitele v USA. Charter by mohl část provozu SpaceX vést přes svou pozemní internetovou infrastrukturu.
The SpaceX logo in this illustration taken June 11, 2026. REUTERS/Dado Ruvic/Illustration Purchase Licensing Rights, opens new tab
June 26 (Reuters) - SpaceX (SPCX.O), opens new tab and internet provider Charter Communications (CHTR.O), opens new tab have held executive-level talks about partnering on a consumer mobile phone offering in the United States, Bloomberg News reported on Friday, citing sources.
The Reuters Inside Track newsletter is your essential guide during the World Cup. Sign up here.
SpaceX already offers direct-to-cell connectivity with T-Mobile in the U.S., providing supplemental coverage from space to extend internet access to remote areas.
Charter could run some of SpaceX's phone traffic through its ground-based internet infrastructure, the report said.
Reuters could not immediately verify the report. The companies did not immediately respond to a Reuters request for comment outside office hours.
SpaceX has told investors it plans to launch a Starlink mobile service for U.S. consumers, the Financial Times reported earlier on Friday, which could allow the Elon Musk-led company to compete directly with Verizon (VZ.N), opens new tab, AT&T (T.N), opens new tab and T-Mobile (TMUS.O), opens new tab.
Reporting by Natalia Bueno Rebolledo in Mexico City; Editing by Sahal Muhammed and Edmund Klamann
Our Standards: The Thomson Reuters Trust Principles., opens new tab
GameStop čeká ve fiskálním roce 2026 upravená EBITDA přes 600 milionů USD, proti 345,4 milionu USD v roce 2025. Firma zároveň pokračuje v přípravě navrhované akvizice eBay.
GRAPEVINE, Texas--(BUSINESS WIRE)--GameStop Corp. (NYSE: GME) (“GameStop” or the “Company”) today announced that, for the fiscal year ending January 30, 2027 ("fiscal year 2026"), the Company currently expects to generate Adjusted EBITDA in excess of $600 million, compared to Adjusted EBITDA of $345.4 million in fiscal year 2025.
GameStop's leadership team remains focused on advancing the proposed acquisition of eBay, Inc. ("eBay"). Additional materials regarding the proposed transaction are forthcoming.
A Current Report on Form 8-K furnishing the Company's fiscal year 2026 outlook has been filed with the Securities and Exchange Commission and is available at www.sec.gov and on the Company's investor relations website at investor.gamestop.com.
NON-GAAP MEASURES AND OTHER METRICS
As a supplement to the Company’s financial results presented in accordance with U.S. generally accepted accounting principles ("GAAP"), GameStop may use certain non-GAAP measures, including adjusted EBITDA. Adjusted EBITDA is a supplemental financial measure of the Company’s performance that is not required by, or presented in accordance with, GAAP. We believe that the presentation of this non-GAAP financial measure provides useful information to investors in assessing our core operating performance, financial condition and results of operations. We define adjusted EBITDA as net income before income taxes, plus interest income, net and depreciation and amortization, excluding stock-based compensation, certain transformation costs (including severance and other costs), business divestitures, asset impairments, gain (loss) on digital assets and related receivables, unrealized gain (loss) on derivative assets, and other non-cash charges. Net income is the GAAP financial measure most directly comparable to adjusted EBITDA. Our non-GAAP financial measures should not be considered as an alternative to the most directly comparable GAAP financial measure. Furthermore, non-GAAP financial measures have limitations as an analytical tool because they exclude some but not all items that affect the most directly comparable GAAP financial measures. Some of these limitations include:
certain items excluded from adjusted EBITDA are significant components in understanding and assessing a company’s financial performance, such as a company’s cost of capital and tax structure, results of operations or cash flows; adjusted EBITDA does not reflect our cash expenditures or future requirements for capital expenditures or contractual commitments; adjusted EBITDA does not reflect changes in, or cash requirements for, our working capital needs; although depreciation and amortization are non-cash charges, the assets being depreciated and amortized will often have to be replaced in the future, and adjusted EBITDA does not reflect any cash requirements for such replacements; and our computations of adjusted EBITDA may not be comparable to other similarly titled measures of other companies. We compensate for the limitations of adjusted EBITDA as analytical tools by reviewing the comparable GAAP financial measure, understanding the differences between the GAAP and non-GAAP financial measures and incorporating these data points into our decision-making process. Adjusted EBITDA is provided in addition to, and not as an alternative to, the Company’s financial results prepared in accordance with GAAP, and should not be considered in isolation or as a substitute for analysis of our results as reported under GAAP. Because adjusted EBITDA may be defined and determined differently by other companies in our industry, our definitions of this non-GAAP financial measure may not be comparable to similarly titled measures of other companies, thereby diminishing their utility.
With regards to forward-looking guidance for adjusted EBITDA, we are not able to reconcile the forward-looking non-GAAP measure of adjusted EBITDA to the closest corresponding GAAP measure, net income, without unreasonable efforts because we are unable to predict the ultimate outcome of certain significant items.
This Press Release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. In some cases, forward-looking statements can be identified by the use of terms such as "anticipates," "believes," "continues," "could," "estimates," "expects," "intends," "may," "plans," "potential," "predicts," "pro forma," "seeks," "should," "will" or similar expressions. Forward-looking statements are subject to significant risks and uncertainties and actual developments, business decisions, outcomes and results may differ materially from those reflected or described in the forward-looking statements. The following factors, among others, could cause actual developments, business decisions, outcomes and results to differ materially from those reflected or described in the forward-looking statements: the performance of our business and our ability to generate earnings in line with our guidance; economic, social, and political conditions in the markets in which we operate; the competitive nature of the Company’s industry; the cyclicality of the video game industry; the Company’s dependence on the timely delivery of new and innovative products from its vendors; the impact of technological advances in the video game industry and related changes in consumer behavior on the Company’s sales; interruptions to the Company’s supply chain or the supply chain of our suppliers; the Company’s dependence on sales during the holiday selling season and on the popularity and sale of trading cards; the Company’s ability to obtain favorable terms from its current and future suppliers and service providers; the Company’s ability to anticipate, identify and react to trends in pop culture with regard to its sales of collectibles; the Company’s ability to maintain strong retail and ecommerce experiences for its customers; the Company’s ability to keep pace with changing industry technology and consumer preferences; how the Company incorporates artificial intelligence into workflows and processes, including customer-facing and operational activities, and challenges with properly managing its use; the Company’s ability to manage its profitability and cost reduction initiatives; the Company’s ability to complete its proposed acquisition of eBay Inc.; changes in senior management or the Company’s ability to attract and retain qualified personnel; the Company is highly dependent on the services of the Company’s Chairman of the Board and Chief Executive Officer, Ryan Cohen; if the grant of a 100% performance-based nonqualified stock option award (the “CEO Performance Award”) to Mr. Cohen is not approved by the Company’s stockholders or if the Company is unable to adequately incentivize Mr. Cohen to maintain his focus and priorities on the Company, the Company's ability to execute on its strategy and achieve its growth goals may be adversely impacted; the CEO Performance Award, if and to the extent the stock options associated become vested and are exercised, would result in dilution to the Company’s stockholders and could impact the Company’s stock price; potential damage to the Company’s reputation or customers' perception of the Company; the Company's ability, or the ability of the third parties with whom we work, to maintain the security of our information technology systems or data (including customer, associate or Company information); the Company's compliance with stringent and evolving laws and other obligations related to data privacy and security; occurrence of weather events, natural disasters, public health crises and other unexpected events; risks associated with inventory shrinkage; potential failure or inadequacy of the Company's computerized systems; the ability of the Company’s third party delivery services to deliver products to the Company’s retail locations, fulfillment centers and consumers and changes in the terms the Company has with such service providers; the ability and willingness of the Company’s vendors to provide marketing and merchandising support at historical or anticipated levels; restrictions on the Company’s ability to purchase and sell pre-owned products; the Company’s ability to renew or enter into new leases on favorable terms; unfavorable changes in the Company’s global tax rate; legislative actions; the Company’s ability to comply with federal, state, local and international laws and regulations and statutes; changes to tariff and import/export regulations; potential litigation and other legal proceedings; the value of the Company's investment holdings; concentration of the Company's investment portfolio into one or fewer holdings; the recognition of losses in a particular investment even if the Company has not sold the investment; the execution and timing of share repurchases, if any, under the share repurchase authorization; volatility in the Company’s stock price, including volatility due to potential short squeezes; continued high degrees of media coverage by third parties; the availability and future sales of substantial amounts of the Company’s Class A common stock; the issuance of common stock upon the exercise of the warrants declared as part of the October 7, 2025 distribution to the holders of record of the Company's Class A common stock and holders of the Convertible Notes, in the form of warrants to purchase shares of common stock (the “Warrants”), may depress our stock price; future issuance of additional warrants may adversely affect the market price of the Warrants and the market price of the Company’s common stock; the Warrants do not automatically exercise, and any Warrant that is not exercised prior to their expiration date will lose all financial value; fluctuations in the Company’s results of operations from quarter to quarter; the Company’s ability to generate sufficient cash flow to fund its operations; the $1.5 billion 0.00% Convertible Senior Notes due 2030 (the “Convertible 2030 Notes") and $2,250.0 million 0.00% Convertible Senior Notes due 2032 (the "Convertible 2032 Notes" and, collectively with the Convertible 2030 Notes, the "Convertible Notes") are the Company’s obligations only, and substantially all of our operations are conducted through, and a portion of our consolidated assets are held by, our subsidiaries; servicing the Convertible Notes requires a significant amount of cash, and the Company may not have sufficient cash flow from our business to make such payments, and we may incur additional indebtedness in the future; the Company’s ability to incur additional debt; risks associated with the Company’s investment in marketable, nonmarketable and interest-bearing securities, including the impact of such investments on Company’s financial results; the Company's investment policy permits investments in certain cryptocurrency assets, including Bitcoin and U.S. dollar-denominated stable coins, and to the extent the Company holds Bitcoin or U.S. dollar denominated stable coins, the Company will be exposed to certain risks associated with Bitcoin or stable coins, respectively; the Company’s derivative strategy can expose it to counterparty risk; and the Company’s ability to maintain effective internal control over financial reporting. Additional factors that could cause results to differ materially from those reflected or described in the forward-looking statements can be found in GameStop's most recent Annual Report on Form 10-K and other filings made from time to time with the Securities and Exchange Commission and available at www.sec.gov or on the Company’s investor relations website (https://investor.gamestop.com). Forward-looking statements contained in this Press Release speak only as of the date of this Press Release. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by any applicable securities laws.
Preliminary Financial Information
We report our financial results in accordance with U.S. generally accepted accounting principles. All projected financial information in this Press Release is preliminary. These estimates are not a comprehensive statement of our financial position and results of operations. There is no assurance that the Company will achieve its forecasted results within the relevant period or otherwise. Actual results may differ materially from these estimates as a result of actual quarter-end results, the completion of normal quarter-end accounting procedures and adjustments, including the execution of our internal control over financial reporting, the completion of the preparation and management’s review of our financial statements for the relevant period and the subsequent occurrence or identification of events prior to the filing of our financial results for the relevant period with the Securities and Exchange Commission.
No Offer or Solicitation
This communication relates to a business combination involving GameStop and eBay that has been proposed by GameStop (the “Proposed Transaction”). This communication is for informational purposes only and is neither an offer to sell or purchase, nor the solicitation of an offer to buy or sell, any securities (or the solicitation of any proxy or vote with respect to any matter), nor shall there be any sale or purchase, issuance or other transfer of securities (or the solicitation of any proxy or other vote) with respect to the Proposed Transaction or otherwise in any jurisdiction in contravention of applicable law. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the U.S. Securities Act of 1933, as amended.
Certain Information Regarding Participants
GameStop and its directors and certain of its executive officers may be considered participants in the solicitation of proxies in connection with the Proposed Transaction, should the Proposed Transaction and any such solicitation occur. Information about the directors and executive officers of GameStop is set forth in GameStop’s definitive proxy statement for the 2026 Annual Meeting of Stockholders to be held July 7, 2026 at 10:00 a.m. CDT, which was filed with the SEC on May 22, 2026 (as supplemented from time to time, the “2026 Proxy Statement”), which is available here, including under the headings “Proposal 1: Election of Directors”, “Director Nomination Process”, “The Director Nominees”, “Director Nominee Qualifications and Experience”, “Biographies of Director Nominees”, “The Board of Directors”, “Corporate Governance”, “Director Compensation”, “Executive Officers”, “Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters”, “Compensation Committee Interlocks and Insider Participation”, “Proposal No. 2: Advisory Vote on Executive Compensation”, “Compensation Discussion and Analysis”, “Offer Letters and Severance/Change in Control Benefits”, “Compensation Committee Report on Executive Compensation”, “Executive Compensation Tables”, “CEO Pay Ratio”, “Pay Versus Performance”, “Equity Grant Practices”, “Securities Authorized for Issuance Under Equity Compensation Plans”, “Audit Committee Matters”, “Certain Relationships and Related Transactions”, “Proposal 4: Approval of CEO Performance Award”, “Summary of the Proposed CEO Performance Award”, “Reasons for Approval of the CEO Performance Award”, “Market Capitalization Hurdles with Cumulative Performance EBITDA Hurdles Create Real Value for Stockholders”, “Background of the CEO Performance Award”, “Key Terms of the Proposed CEO Performance Award”, “Other Details Regarding the Proposed CEO Performance Award”, “The Compensation Committee’s Assessment of the CEO Performance Award”, “Practical Implications of the CEO Performance Award” and “Appendix A: CEO Performance Award Agreement”. To the extent holdings of such persons in the Company’s securities have changed since the amounts described in the 2026 Proxy Statement, such changes have been reflected on Initial Statements of Beneficial Ownership on Form 3 or Statements of Change in Ownership on Form 4 filed with the SEC. Additional information can also be found in the Company’s Annual Report on Form 10-K for the fiscal year ended January 31, 2026, filed with the SEC on March 24, 2026, which is available here.
As of the date hereof, GameStop directly beneficially owns 4,343,725 shares of common stock of eBay, par value $0.001 per share (the “Common Stock”), and has further entered into the long-side of a series of American-style put/call option transactions (the “Put/Call Pairs”), expiring February 23, 2028, with an unaffiliated financial institution counterparty that provide economic exposure to a further 39,046,658 shares of Common Stock. The Put/Call Pairs were only settleable in cash until such time as GameStop provided the unaffiliated financial institution counterparty with reasonable evidence that all applicable filings had been made and any applicable waiting periods had expired or approvals had been received, as applicable, under the Hart Scott Rodino Antitrust Improvements Act of 1976, as amended (the “HSR Act Condition”). On June 3, 2026, the HSR Act Condition was satisfied, and as a result, GameStop (in the case of the call portion of the Put/Call Pairs) and the unaffiliated financial institution counterparty (in the case of the put portion of the Put/Call Pairs) electing to settle the Put/Call Pairs now have the option, but not the obligation, to elect for physical settlement of the shares of Common Stock underlying such Put/Call Pairs in lieu of cash settlement. GameStop does not have voting power or dispositive power with respect to the shares of Common Stock underlying such Put/Call Pairs unless and until such Put/Call Pairs are physically settled for Common Stock. On May 3, 2026, GameStop delivered to the board of directors of eBay a non-binding proposal to acquire all of the outstanding Common Stock that it does not already own at a price of $125 per share of Common Stock, to be paid in a combination of cash and GameStop common stock. As a result of the foregoing, GameStop may be deemed to have direct or indirect interests with respect to eBay that are in addition to, or different from, those of other eBay shareholders.
Further information regarding the participants in the proxy solicitations and a description of their direct and indirect interests, by security holdings or otherwise, will be contained in any proxy statement/prospectus and/or other relevant materials to be filed with the SEC in connection with the Proposed Transaction when they become available.
Disclaimer
Any information concerning eBay contained in this communication has been taken from, or based upon, publicly available information. Although GameStop does not have any information that would indicate that any information contained in this communication that has been taken from such documents is inaccurate or incomplete, GameStop does not take any responsibility for the accuracy or completeness of such information. To date, GameStop has not had access to the books and records of eBay.
Ares Capital (ARCC) v poslední seanci vzrostla o 1,11 % na 18,19 USD, i když širší trh klesal. Před zveřejněním výsledků se čeká EPS 0,47 USD a výnosy 776,52 mil. USD.
In the latest close session, Ares Capital (ARCC - Free Report) was up +1.11% at $18.19. This change outpaced the S&P 500's 0.05% loss on the day. Meanwhile, the Dow lost 0.09%, and the Nasdaq, a tech-heavy index, lost 0.24%.
Shares of the private equity firm have depreciated by 4.36% over the course of the past month, underperforming the Finance sector's gain of 2.3%, and the S&P 500's loss of 1.42%.
The investment community will be closely monitoring the performance of Ares Capital in its forthcoming earnings report. The company is expected to report EPS of $0.47, down 6% from the prior-year quarter. Meanwhile, the latest consensus estimate predicts the revenue to be $776.52 million, indicating a 4.23% increase compared to the same quarter of the previous year.
Regarding the entire year, the Zacks Consensus Estimates forecast earnings of $1.91 per share and revenue of $3.14 billion, indicating changes of -4.98% and +2.98%, respectively, compared to the previous year.
Investors might also notice recent changes to analyst estimates for Ares Capital. These recent revisions tend to reflect the evolving nature of short-term business trends. Hence, positive alterations in estimates signify analyst optimism regarding the business and profitability.
Empirical research indicates that these revisions in estimates have a direct correlation with impending stock price performance. To capitalize on this, we've crafted the Zacks Rank, a unique model that incorporates these estimate changes and offers a practical rating system.
The Zacks Rank system, stretching from #1 (Strong Buy) to #5 (Strong Sell), has a noteworthy track record of outperforming, validated by third-party audits, with stocks rated #1 producing an average annual return of +25% since the year 1988. The Zacks Consensus EPS estimate remained stagnant within the past month. Ares Capital presently features a Zacks Rank of #3 (Hold).
With respect to valuation, Ares Capital is currently being traded at a Forward P/E ratio of 9.43. This represents a premium compared to its industry average Forward P/E of 7.92.
The Financial - SBIC & Commercial Industry industry is part of the Finance sector. At present, this industry carries a Zacks Industry Rank of 211, placing it within the bottom 14% of over 250 industries.
The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
To follow ARCC in the coming trading sessions, be sure to utilize Zacks.com.
International Paper oznámila optimalizaci severoamerické sítě a do konce 3. čtvrtletí 2026 zavře závody v Richwoodu, Aurorě, Elk Grove a Barringtonu. Má tím dosáhnout silnější nákladové pozice a vyšší kapacity.
Portfolio changes position the company to better serve customers and support long-term growth
, /PRNewswire/ -- International Paper (NYSE: IP; LSE: IPC), a leader in sustainable packaging, today announced strategic actions that aim to optimize its network, focus investments on the highest-value opportunities and better serve customers across North America. As a result, the company plans to cease its preprint operations at its Richwood, KY facility, and close its Aurora, IL sheet plant and converting plants in Elk Grove, CA and Barrington, NJ by the end of the third quarter 2026.
The decision reflects International Paper's ongoing strategy to strengthen its cost position, increase capacity, and provide customers with the highest quality sustainable packaging solutions.
"These are difficult but necessary decisions that strengthen our network, focus investments where they create the greatest value and position International Paper to better serve customers and compete for the long term. We are grateful to the employees affected and are committed to supporting them through this transition and ensuring a seamless experience for our customers," said Tom Hamic, Executive Vice President and President, Packaging Solutions North America, International Paper.
International Paper will support impacted employees with outplacement assistance, severance and benefits. The company expects to transition affected customers to other facilities within each region to ensure continuity of supply.
About International Paper (NYSE: IP; LSE: IPC)
International Paper creates sustainable packaging solutions that enable our customers, teammates and shareowners to thrive in an ever-changing world. We are a leader in corrugated packaging, partnering with customers across industries to protect what matters most, strengthen supply chains and create lasting value. Learn more at internationalpaper.com.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements can be identified by the use of forward-looking or conditional words such as "intend," "aim," "may," "will," "expect," and "plan" or similar expressions. These forward-looking statements reflect management's current views and are subject to risks and uncertainties that could cause actual results and the timing of events to differ materially from those expressed or implied in these forward-looking statements. These risks and uncertainties include the risk of the Company's ability to achieve the desired outcome and realize the anticipated benefits from its strategic transformation initiatives. These forward-looking statements are also subject to the risks and uncertainties contained in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2025, filed with the U.S. Securities and Exchange Commission ("SEC") on February 21, 2026, and subsequent reports filed with the SEC. In addition, other risks and uncertainties not presently known to the Company or that we currently believe to be immaterial could affect the accuracy of any forward-looking statements. The Company undertakes no obligation to publicly update any forward-looking statements contained in this press release, whether as a result of new information, future events or changes in expectations.
Grayscaleův HYPG se stal největším stakingovým fondem v síti Hyperliquid, spravuje 123,28 mil. USD a drží 1 941 165 HYPE. V USA je zároveň nejlevnějším regulovaným produktem pro expozici vůči HYPE s poplatkem 0,29 %.
Grayscale's HYPG Leads the Hyperliquid ETF Race@Grayscale's Hyperliquid Staking ETF, trading under the ticker $HYPG on Nasdaq, has emerged as the dominant institutional product in the fast-growing $HYPE ETF category. As of June 26, 2026, the fund manages $123.28M in assets and holds 1,941,165 $HYPE tokens, placing it ahead of rival products from 21Shares and Bitwise by assets under management.
Grayscale launched $HYPG on Nasdaq with a 0.29% sponsor fee, undercutting rival Hyperliquid funds from 21Shares and Bitwise. 21Shares debuted its fund (THYP) on Nasdaq on May 12 with a 0.30% fee, while Bitwise followed with its BHYP ETF, initially waiving fees before stepping up to 0.34% upon the end of the promotional window. That makes $HYPG the most cost-effective regulated vehicle for $HYPE exposure currently available in the United States.
Staking Rewards Built Into the Structure Unlike traditional crypto ETFs that simply hold an underlying asset, $HYPG is designed to generate additional returns through staking. The fund participates in the Hyperliquid network's staking process, allowing investors to capture staking rewards through the ETF structure. Grayscale cites historical staking rewards of about 2.2% annually. Those rewards, net of fees and expenses, flow through to the fund's net asset value, offering investors a potential return beyond simple price appreciation.
Hyperliquid began as a decentralized perpetual futures exchange but has expanded into a broader blockchain ecosystem that supports smart contracts, tokenized assets, and new financial markets. The protocol generated about $857 million in revenue during 2025, with almost 99% directed toward $HYPE buybacks, a model that ties network usage directly to the token's value.
$HYPG is the third U.S.-listed Hyperliquid fund, with HYPE ETFs already topping $132 million in inflows. That pace of adoption reflects a broader shift in how institutional investors are approaching DeFi infrastructure. The fund's debut adds another sign that institutional investors are increasingly looking beyond bitcoin and ether toward crypto-native infrastructure projects that generate revenue and resemble traditional financial networks.
As with any staking product, risks apply. When a fund stakes its underlying asset, the token is subject to staking risks generally, including a lock-up period during which the fund cannot sell or transfer the staked token, making it illiquid for that period. Investors should review the fund's prospectus carefully before committing capital.
Sources:
Grayscale Hyperliquid Staking ETF (HYPG) Official Page
CoinDesk: Grayscale Launches Lowest-Fee U.S. Hyperliquid ETF
GlobeNewswire: Grayscale Official Press Release
Somewhere between a DEX and a full-blown financial exchange, Hyperliquid has built something that most DeFi protocols only claim to be: the dominant venue for trading perpetual futures on-chain. At its peak in 2025, the platform captured more than 80% of decentralized perpetual trading volume. Hyperliquid’s share of on-chain perpetual futures volume sat at 36.4% in January 2026, then climbed to 44% by mid-2026, even as new competitors entered the space.
The scale of what Hyperliquid has actually built Hyperliquid processed $633 billion in trading volume during Q1 2026 alone. Daily volume runs between $3 billion and $10 billion depending on market conditions. Cumulative lifetime volume crossed $4.726 trillion by June 2026.
Advertisement
The platform runs on its own Layer-1 blockchain, built on a consensus mechanism called HyperBFT. Collateral on the platform settles in USDC. The protocol offers leverage up to 40x across more than 300 markets. Those markets now extend beyond crypto perpetuals into commodities, indices, prediction markets, and real-world assets, all made possible through the platform’s HIP-4 framework.
Revenue, the HYPE token, and what traders are actually paying for Hyperliquid generated over $800 million in revenue in 2025. Recent weekly revenue has averaged around $11 million, which annualizes to roughly $570 million at that pace.
The HYPE token launched on November 29, 2024, with approximately 31% of supply allocated to a user airdrop. It subsequently reached all-time highs near $77. The token has attracted ETF investment interest and serves a functional purpose: revenue generated by the protocol flows back to HYPE holders through distributions and token burns.
Total value locked on the platform has ranged between $1 billion and $6 billion depending on market conditions.
The 30-day trading volume reached $237 billion by mid-2026.
Disclosure: This article was edited by Editorial Team. For more information on how we create and review content, see our Editorial Policy.
Hyperliquid generuje anualizované tržby kolem 700 milionů USD z 3 miliard USD kolaterálu a už překročil 1 miliardu USD kumulativních příjmů. Platforma od spuštění zpracovala přes 4,7 bilionu USD v objemu perpetual futures.
Think of Hyperliquid as a casino that built itself without taking a dime from investors, and now generates roughly 23 cents in annual revenue for every dollar deposited on its platform. That’s the math when you divide $700 million in annualized revenue by $3 billion in collateral.
The numbers behind the machine Hyperliquid’s annualized revenue figures range between $700 million and $1.2 billion, depending on the measurement window. Cumulative revenue has already crossed the $1 billion mark, with 30-day revenue running at approximately $60 million.
The engine powering those figures is trading volume. The platform has processed over $4.7 trillion in cumulative perpetual futures volume since launch. Recent 30-day perp volume exceeds $250 billion, and open interest sits at roughly $9 billion.
The platform’s activity has drawn comparisons to Nasdaq.
Advertisement
The fee structure is lean. Maker fees sit at 0.015%, taker fees at 0.045%, and gas fees are zero. Hyperliquid directs 99% of certain fee revenues toward purchasing its native token, HYPE, on the open market.
How Hyperliquid got here without VC money The platform launched around 2023 and bootstrapped its way to relevance without venture capital funding. It runs on a custom Layer-1 blockchain using HyperBFT consensus, which enables a fully on-chain order book.
The native token, HYPE, currently trades around $64 to $65 with a market capitalization of approximately $14 billion. It has touched an all-time high of $77. Staking rewards and fee discounts give holders practical reasons to stay engaged beyond simple price speculation.
Recently, Hyperliquid has expanded beyond crypto perpetuals into new territory. The platform introduced off-chain event contracts and S&P 500 perps, positioning itself to compete not just with other DEXs, but with centralized exchanges and prediction markets like Polymarket.
What this means for investors The absence of venture capital in Hyperliquid’s cap table means there are no early investors sitting on heavily discounted tokens waiting to dump at the first opportunity and no unlock schedule hanging over the market. The token’s price dynamics are driven primarily by buybacks, staking demand, and organic trading activity.
Hyperliquid’s revenue is overwhelmingly dependent on perpetual futures trading volume. The expansion into event contracts and traditional equity perps looks like a hedge against concentration in that single revenue source.
For anyone evaluating HYPE as an investment, the 99% fee-to-buyback ratio creates a direct link between platform usage and token demand. With a $14 billion market cap already baked in, the question is whether the current valuation already prices in continued dominance, or whether $250 billion in monthly volume is just the beginning of something much larger.
Disclosure: This article was edited by Editorial Team. For more information on how we create and review content, see our Editorial Policy.
Akcie Braze vyskočily o 7,4 % po novém doporučení Buy od Goldman Sachs a díky oživení softwarového sektoru. Firma zároveň vykázala tržby ve výši 211 milionů USD, což je meziročně o 30 % více.
Braze (BRZE +7.41%) shares jumped on Friday, finishing the day up 7.4%. The S&P 500 and the Nasdaq Composite finished down 0.7% and 0.5%, respectively.
The customer-engagement software company's stock is getting a lift from two main catalysts: a "Buy" rating from Goldman Sachs and a broader rebound in software stocks.
Today's Change
(
7.41
%) $
1.45
Current Price
$
21.02
Goldman Sachs sees Braze as a winner On June 24, Goldman Sachs analyst Callie Valenti assumed coverage of Braze with a Buy rating and a $34 price target -- roughly 77% above where the stock had been trading.
Software stocks have been under pressure Braze stock is down about 40% over the past six months as part of a larger sell-off in software stocks. The market has been fearful that AI models from OpenAI and Anthropic could simply replace what software stocks like Braze do. That fear is easing.
Source: Getty Images
Braze's growth is strong, but profitability remains elusive In its most recent quarter, Braze posted revenue of $211 million, up 30% year over year, alongside record free cash flow and a full-year guidance raise.
Unfortunately, the company continues to struggle to turn a profit, losing just shy of $27 million last quarter. If the company can reverse that, Braze stock could take off.
Johnny Rice has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Braze and Goldman Sachs Group. The Motley Fool has a disclosure policy.
The Securities and Exchange Commission (SEC) and the Commodity Futures Trading Commission (CFTC) have jointly called for public comment on their approach to harmonizing regulatory frameworks for crypto futures. The proposed public comment on the SEC CFTC framework comes amid the recent approval of crypto perpetual futures in the U.S.
Calls For Public Comment On SEC CFTC Framework In a press release, the SEC and CFTC issued a joint request for public comment on potential approaches to further harmonize regulatory frameworks applicable to portfolio margining across securities, security-based swaps, futures, swaps, and related positions. The public comment period will remain open for 60 days after the publication in the Federal Register. This is significant as the CFTC notably regulates prediction markets, which trade swaps.
Furthermore, this follows the launch of crypto perpetual futures in the U.S., with Kalshi securing CFTC approval to offer BTC, ETH, XRP, and HYPE futures. The request for public comment on the SEC CFTC framework also comes amid the rise in tokenized securities, with platforms such as Hyperliquid offering perpetuals for these securities.
The SEC and CFTC noted that the request for comment will assist them in evaluating whether greater coordination or alignment in portfolio margining requirements may improve risk management efficiency, reduce unnecessary market fragmentation, and enhance consumer protections.
Meanwhile, this marks the latest coordination between the SEC and CFTC towards providing clear frameworks that boost the crypto and financial markets. As CoinGape reported, the SEC and CFTC are pushing to clarify the definitions of derivative products, including definitions of swaps and security-based swaps, and how to treat them.
A Move To Further Promote Innovation SEC Chair Paul Atkins noted that further harmonizing the SEC CFTC framework will ensure that jurisdictional overlap does not stifle innovation and efficiency. “Cross-margining offers a clear opportunity to unlock liquidity that remains frozen in separate accounts, and we encourage market participants to provide feedback on ideas that will help improve coordination between both agencies,” he said.
Commenting on this move, CFTC Chair Michael Selig said that fostering enhanced cooperation between the two agencies on portfolio margining promises to unlock untapped capital while ensuring a more robust risk management framework and market protections. The CFTC is currently facing a lawsuit from the CME over its approval of crypto futures.
The CME argues that crypto perpetuals are swaps, not futures contracts, and that the regulator approved these products the wrong way. These crypto futures are already seeing significant demand, with Kalshi’s products recording over $1 billion in trading volume in under two weeks after they launched.
Návrh LendingProtocol na XRP Ledger získal další kladný hlas od xpmarket a směřuje k aktivaci. Pokud projde, přinese Single Asset Vaults, úvěrový protokol a on-chain trh s dluhopisy.
Cover image via depositphotos.com Disclaimer: The opinions expressed by our writers are their own and do not represent the views of U.Today. The financial and market information provided on U.Today is intended for informational purposes only. U.Today is not liable for any financial losses incurred while trading cryptocurrencies. Conduct your own research by contacting financial experts before making any investment decisions. We believe that all content is accurate as of the date of publication, but certain offers mentioned may no longer be available.
The native lending protocol on the XRP Ledger (XRPL) received an important boost today toward final activation. An XRPL Foundation representative known as Vet reported that the built-in amendment gained another critically important "YES" vote.
It came from the official on-chain support of major ecosystem platform xpmarket, which voted in favor of the XLS-65 and XLS-66 upgrade package. The platform's developers confirmed that this step opens the way for Single Asset Vaults, an on-chain bond market, and direct yield generation.
👾 XPMarket has voted YES on XLS-65 and XLS-66!
🚀XPMarket is backing native lending on the XRPL.
These amendments bring Single Asset Vaults and an on-chain Lending Protocol directly to the ledger, unlocking yield, liquidity pools, and credit markets with no external smart… pic.twitter.com/UZi6cSDFtI
— xpmarket.com (@xpmarket) June 26, 2026 The LendingProtocol amendment is currently in VOTING status, and at the moment consensus stands at 20% — 7 out of 35 key validators have voted "YES." For the code to be finally implemented at the network's base level, it needs to reach the threshold of 28 votes and maintain it for two weeks.
As Vet notes, validators have started changing their positions more actively in favor of the update thanks to the community's new, stricter approach to security and amendment review.
HOT Stories
Different kind of crypto lending market for XRPInterest in the event is being fueled by the architecture of the protocol itself. Unlike traditional DeFi based on smart contracts, RippleX embeds lending logic directly into the blockchain core at Layer 1. It consists of two elements:
XLS-65 (Single Asset Vaults): users pool one type of asset, such as XRP or the RLUSD stablecoin, into a shared vault.XLS-66 (Lending Protocol): the system issues fixed-term loans from this pool and distributes income among depositors. You Might Also Like
The main difference from crypto's classic model is that the loans will be unsecured. There is no collateral here, and the entire model is closer to the traditional bond market and credit desks in TradFi. Risks are assessed outside the network through off-chain underwriting: the lender independently verifies the borrower's identity and reliability before issuing funds.
Voting continues, but the ice has broken — application developers on the XRP Ledger have already started designing interfaces so users can interact with loans as soon as validators lock in the final 28 votes.
Polymarket dává 76% šanci, že Ethereum do konce roku 2026 spadne na 1 500 USD. ETH navíc čelí rekordním odlivům z ETF a odloženému upgradu Glamsterdam.
Polymarket traders assign a 76% probability that Ethereum will reach $1,500 before the end of 2026, reflecting near-total conviction in further downside from current levels. U.S. spot Ethereum ETFs recorded 17 consecutive days of net outflows totaling $401 million in May 2026, setting the longest institutional withdrawal streak in ETH history. A confirmed death cross on the daily chart, where the 50-day EMA crossed below the 200-day EMA, preceded months of further decline in both prior Ethereum bear markets. The Glamsterdam protocol upgrade, originally targeting June 2026, has been delayed to Q3 2026, removing the primary near-term catalyst that bulls had used to anchor support. Ethereum trades below its 20-day, 50-day, and 100-day exponential moving averages, all clustered between $1,740 and $2,050, creating a dense resistance wall above current price action. Ethereum traded near $1,670 on June 25, 2026, holding just above a support zone that has protected every major low since the 2022 bear market bottom. The $1,500 level has drawn $3.9 million in total volume on Polymarket prediction markets alone, where traders now price a 76% chance that ETH reaches that threshold before year-end.
That conviction stems from a convergence of signals: record ETF outflows, a confirmed death cross, and a delayed protocol upgrade that had been the last remaining bullish catalyst for Q2.
This article examines the technical, fundamental, and on-chain data behind the growing consensus that $1,500 is no longer a floor but a destination, and what that shift means for positioning.
Record ETF Outflows Signal Institutional Retreat U.S. spot Ethereum ETFs logged 17 consecutive trading days of net outflows in May, totaling $401 million and setting a record for the longest institutional withdrawal streak Ethereum has experienced.
On June 23 alone, ETH ETFs recorded $82 million in net outflows, marking the fourth straight day of withdrawals as market caution grew amid U.S.-Iran tensions and shifting interest rate expectations. The institutional retreat contrasts sharply with the accumulation thesis that dominated late 2025.
When spot ETH ETFs launched, proponents argued that regulated institutional vehicles would create a persistent demand floor.
That thesis has not survived contact with a 65% drawdown from the approximately $4,950 all-time high reached in August 2025. Funding rates have turned negative and open interest has declined sharply, suggesting a leverage flush rather than a fresh uptrend, according to data reviewed by Cryptopolitan analysts.
Death Cross and Descending Channel Frame the Technical Picture A death cross confirmed on the daily chart when the 50-day exponential moving average crossed below the 200-day EMA. In Ethereum’s prior bear markets of 2018 and 2022, this signal preceded months of further decline before any sustained recovery began.
ETH currently trades below its 20-day, 50-day, and 100-day EMAs, all clustered between $1,740 and $2,050. That alignment creates a dense resistance wall. Analyst Ardi stated on X that ETH has one responsibility over the next four months: do not start closing below $1,500.
He noted the level has held every major low since the 2022 bottom, and losing it would force a reconsideration of bullish assumptions, Ardi wrote on June 24. Immediate support sits at $1,585, with a deeper floor at $1,468 if the current level fails.
Glamsterdam Delay Removes the Last Bullish Catalyst The Glamsterdam upgrade represents Ethereum’s most significant protocol change since the Merge. Originally targeting June 2026, the upgrade has been officially delayed to Q3 2026, removing the primary catalyst that bulls had been using to anchor a price floor for the current quarter.
Glamsterdam’s two headline components are Enshrined Proposer-Builder Separation (ePBS) and Block-Level Access Lists (BALs). The ePBS feature removes reliance on third-party MEV relays to match block builders with validators.
BALs enable parallel transaction execution by requiring each block to declare upfront which accounts it will read and write. A confirmed 200-million-gas limit floor was set at the Soldøgn Interop in April 2026, representing a 233% increase from the current limit.
Analysis: The delay matters because price catalysts derive their power from proximity. A Q2 upgrade creates a tradable event in the present quarter; a Q3 timeline pushes it into seasonal low-volume months, reducing the probability that institutional capital will front-run the event.
Prediction Markets Quantify the Downside Consensus Polymarket now prices a 76% chance that ETH hits $1,500 before year-end, while Kalshi shows 73%. That level of convergence across two independent prediction platforms is unusual.
The $1,500 zone aligns with a high-footprint anchored volume profile, according to Coinpedia analysis, meaning significant historical volume traded at that price, which can act as either support or a magnet for price.
Analyst James Easton compared Ethereum’s current weekly chart to the Russell 2000 index. The Russell 2000 has broken above its resistance near 2,500, but Ethereum remains below its equivalent zone near $4,300 to $5,100.
A confirmed move above approximately $5,100 could place Ethereum in price discovery, Easton noted, though that requires a reversal of the current downtrend as a prerequisite.
Regulatory Implications The SEC has not issued new guidance on spot Ethereum ETFs during the current drawdown. If outflows continue at the current pace, issuers may face pressure to reduce fees or restructure fund terms to stem redemptions.
The delayed Glamsterdam upgrade also raises questions about whether the SEC’s classification framework for ETH could shift if staking mechanics change significantly post-upgrade.
What’s Next? The immediate test is whether ETH can hold above $1,585 and reclaim $1,685 on a daily close. The Glamsterdam upgrade timeline in Q3 2026 provides the next fundamental catalyst. Prediction market pricing currently embeds an assumption that the $1,500 test is a matter of when, not if.
FAQs What does the Ethereum death cross mean for price?
A death cross occurs when the 50-day EMA crosses below the 200-day EMA, signaling medium-term momentum has turned negative relative to the long-term trend.
How many consecutive days of ETH ETF outflows occurred?
U.S. spot Ethereum ETFs recorded 17 consecutive days of net outflows in May 2026, totaling $401 million and setting a record for institutional ETH withdrawal streaks.
What is the Glamsterdam upgrade for Ethereum?
Glamsterdam is Ethereum’s next major protocol upgrade, featuring Enshrined Proposer-Builder Separation and Block-Level Access Lists, now delayed from June to Q3 2026 release.
What probability do prediction markets assign to ETH hitting $1,500?
Polymarket prices a 76% chance, and Kalshi shows 73% probability that ETH will reach $1,500 before the end of the 2026 calendar year.
Where is the next major Ethereum support level?
Immediate support sits at $1,585 with a deeper floor at $1,468, and the $1,500 level aligns with anchored volume profile data from prior cycles.
What caused the Ethereum price decline in 2026?
A combination of record ETF outflows, a confirmed death cross, the Glamsterdam upgrade delay, and broader macro risk-off sentiment drove ETH below $1,700.
Can Ethereum recover above $5,000 from current levels?
Analyst James Easton noted a confirmed move above $5,100 could place ETH in price discovery, but the current descending channel must reverse first.
References TechTimes: Ethereum Price Prediction 2026: 17-Day ETF Outflow Record Targets $1,500 Support Analytics Insight: Ethereum Price Today: ETH Holds Critical $1,500 Support Coinpaper: Ethereum Price Prediction: Can $1,500 Support Unlock $5,100? Coinpedia: Ethereum Price Prediction 2026, 2027 – 2030
Čtyři neaktivní peněženky s ETH po téměř osmi letech prodaly 33 623 ETH za 52,5 milionu USD. Podle on-chain dat šlo o realizovaný zisk asi 27,4 milionu USD.
After remaining untouched for nearly eight years, four Ethereum wallets have suddenly reactivated and executed large-scale sales. On-chain data reveals that these wallets collectively offloaded 33,623 ETH within just four hours, at an average price of $1,560 per ETH.
Wallets awakened after years of inactivityThese four wallets originally accumulated a total of 37,602 ETH in 2018, buying in at an average price of around $830 per token. In the latest transactions, most of these holdings were transferred to exchanges and sold off. According to available information, the total proceeds from the sales reached $52.5 million.
Mini glossary: Lookonchain is an on-chain analytics account that tracks blockchain transfers and large wallet movements. Arkham is a blockchain data platform renowned for tracing wallet activity and associating addresses.
Movements tracked by Lookonchain and cross-checked with Arkham data point to a realized profit of approximately $27.4 million based on entry costs. The article shares the wallet addresses involved and notes that these remained largely dormant since their initial accumulation period.
In its post, Lookonchain highlighted that the ETH had been held for eight years before finally being sold, yet even after all that time, the wallets did not benefit from previous, higher market valuations.
While these sales demonstrate that long-term investors can still lock in gains despite weakened market conditions, the profits remain limited compared to what could have been achieved during peak market rallies.
Profits fall short of all-time highsData shows that on paper, these wallets’ holdings once exceeded $150 million during past bull cycles. However, the owners did not sell during the major surges of 2021 and 2025, passing on peak exit opportunities.
Ethereum reached its all-time high of about $4,946 in August 2025. At that level, the wallets in question were worth exponentially more than the recent selling prices. Instead, the most recent sales occurred with ETH trading around $1,560.
ItemDataInitial amount purchased37,602 ETHAverage entry price$830Amount sold33,623 ETHAverage selling price$1,560Total proceeds$52.5 millionRealized profit$27.4 millionAnalysts point out that the divergence between potential peak value and realized profit exposes missed opportunities during past booms. The rapid completion of these recent sales also underscores a trend of long-term Ethereum holders now liquidating some of their positions.
Available data show that these wallets, after years of dormancy, executed sizable sales in a brief period. This pattern resembles recent behavior among other long-standing Ethereum holders.
Similar moves witnessed beforeThis string of transactions marks the latest example of early Ethereum investors reducing their holdings after years on the sidelines. In March, another early adopter sold roughly $31 million worth of Ethereum.
April likewise saw an ICO participant transfer 10,000 ETH, valued at approximately $23 million, after years of inactivity. With these latest moves, the reactivation of previously idle wallets is under close watch by market observers.
Disclaimer: The information contained in this article does not constitute investment advice. Investors should be aware that cryptocurrencies carry high volatility and therefore risk, and should conduct their own research.
Bitmine Immersion Technologies (BMNR) byla zařazena do Russell 1000, což může přilákat miliardové pasivní přílivy. Firma drží asi 5,67 milionu ETH, tedy zhruba 4,7 % nabídky Etherea.
Bitmine Immersion Technologies, trading as BMNR on the NYSE, has met the eligibility criteria for inclusion in the Russell 1000 Index. The addition is expected to take effect on June 26, 2026, following a preliminary list publication in May 2026.
What Bitmine actually is, and why the Russell 1000 matters The company holds approximately 5.67 million ETH, which represents roughly 4.7% of the total Ethereum supply. Combined with cash and other assets, its total holdings clock in at approximately $10.7 billion.
The Russell 1000 Index tracks the largest 1,000 US-listed companies by market capitalization. It serves as a benchmark for large-cap investing, and more importantly, it’s the reference index for a massive ecosystem of passive funds, ETFs, and institutional portfolios that automatically buy whatever the index tells them to buy.
Advertisement
Chairman Tom Lee indicated that the resulting inflows from index trackers could reach into the billions.
The Ethereum thesis, wrapped in a stock ticker BMNR co-founded Ethlabs, a collaborative initiative designed to accelerate Ethereum’s institutional adoption. The effort reportedly involves notable figures from the Ethereum ecosystem, including Joe Lubin.
The company’s investor roster includes ARK Invest, Founders Fund, and Pantera Capital.
The stock trades with high liquidity, reportedly seeing hundreds of millions in daily volume.
What this means for investors When passive funds buy BMNR shares, they’re indirectly gaining exposure to 5.67 million ETH. That means pension funds, 401(k) plans, and retirement accounts benchmarked to the Russell 1000 will, whether they realize it or not, suddenly have a slice of their portfolio tied to the price of Ethereum.
When MSTR entered the Nasdaq 100 in late 2024, it triggered a wave of passive buying that helped stabilize the stock’s premium to its underlying Bitcoin holdings.
The preliminary list drops in May 2026, which gives institutional investors about a month to position ahead of the June 26 effective date.
Disclosure: This article was edited by Editorial Team. For more information on how we create and review content, see our Editorial Policy.
Velcí držitelé přesunuli na Binance přes 10,2 milionu LINK před oznámením Project Pangea. Binance tím zvedla rezervy LINK z 84,1 milionu na 94,3 milionu tokenů.
Large LINK holders moved millions of tokens to Binance before Project Pangea.
There has been a sharp increase in Chainlink tokens moving to exchanges just days before the project announced a major banking initiative.
According to on-chain data from the Ethereum network, Binance recorded a net inflow of more than 10.2 million LINK on June 19. This pushed the exchange’s LINK reserves from 84.1 million to 94.3 million tokens in a single day.
LINK Exchange Supply CryptoQuant said the sudden movement also caused the seven-day average netflow to surge by 20,677% compared with its three-month average, as it highlighted an unusual change in exchange activity. The large transfer took place only a few days before Chainlink unveiled Project Pangea on June 23.
The initiative focuses on T+0 foreign exchange settlement, involves more than 80 banks from Europe and South Korea, and represents over $10 trillion in assets under management. Historically, inflows of this size have increased the amount of tokens available for selling on exchanges and have often been linked to higher market volatility. However, LINK’s price reaction remained relatively limited as it fell from around $8 to approximately $7.3 during the period.
The transfers were also found to be highly concentrated among a small group of large holders. The “inflow_top10” metric was nearly equal to the total inflow volume, which suggests that most of the tokens came from a handful of wallets rather than broader retail participation. CryptoQuant added,
“Although Project Pangea represents a potentially meaningful long-term development for the Chainlink ecosystem, the near-term on-chain picture points to increased exchange supply.”
Despite this increased inflow, more users are holding the token during uncertain market conditions. Santiment reported earlier this month that the number of wallets holding at least 1 LINK has climbed above 535,000, which is the highest level seen since December 2022. The increase came even though LINK remains far below its previous cycle highs.
ETF Flows On the institutional side of things, spot LINK ETF flows turned positive again on June 23 after experiencing their first day of net outflows on June 22. The funds recorded $491,000 in net outflows that day. However, sentiment improved quickly as inflows of about $138,000 returned on June 23. Activity then stalled on June 24, with no net flows recorded.
You may also like: Over 535,000 LINK Holders Signal Quiet Chainlink Accumulation Amid Market Uncertainty HYPE ETFs See Rare First-Week Surge as Eric Balchunas Calls Launch Timing ‘Perfect’ Trump-Linked Truth Social Suddenly Pulls Crypto ETF, Analyst Doubts Reasoning Behind Exit Despite the recent fluctuations, data from SoSoValue revealed that total spot LINK ETF inflows for June currently stand at $3.61 million.
Chainlink mění Build program: místo tokenů projektů bude uzavírat přímé obchodní smlouvy placené v ETH nebo v aktivech převedených do $LINK. Výnosy poputují do Chainlink Reserve.
@chainlink is restructuring how its Build program operates. Rather than collecting native tokens from supported projects, Chainlink Labs will now enter direct commercial agreements paid in ETH or in liquid assets converted into $LINK. The proceeds flow into the Chainlink Reserve.
From Token Allocations to Commercial Deals Since its launch in September 2022, the Build program has aimed to accelerate the growth of early-stage and established projects within the Chainlink ecosystem by providing enhanced access to Chainlink services and technical support. Under the original structure, projects committed a percentage of their total token supply to the Chainlink ecosystem in exchange for those benefits, including incentives to LINK stakers.
That model is now changing. Going forward, Chainlink Labs will strike direct commercial deals with participating projects, with payments denominated in ETH or converted into $LINK before entering the Reserve. The company frames the shift as building sustainable network economics, concentrating value in $LINK rather than distributing a basket of third-party tokens to stakers.
The Chainlink Reserve is a strategic onchain reserve of $LINK designed to support the long-term growth and sustainability of the Chainlink Network. It accumulates LINK tokens using offchain revenue from large enterprises adopting the Chainlink standard and from onchain service usage. The Reserve is built up via Payment Abstraction, onchain infrastructure that lets users pay for Chainlink services in their preferred asset, with payments then programmatically converted to LINK through a decentralized exchange. As of Q1 2026, the Reserve held 3.06 million LINK, with a value of roughly $27.5 million.
Staker Rewards Wind Down as Claims Deadline Approaches The restructuring also marks the end of Chainlink Rewards in its current form. Chainlink Rewards is a community engagement program that enables Build projects to make their native tokens claimable by ecosystem participants, including eligible LINK stakers. The program distributed roughly $20 million worth of project tokens over its run across two seasons.
Season Genesis launched in collaboration with Space and Time, which made 100 million SXT tokens available to eligible LINK stakers. Season 1 followed with nine Build projects, including Dolomite, XSwap, Brickken, Folks Finance, Mind Network, Suku, Truflation, and bitsCrunch, and introduced a more advanced engagement and claiming mechanism. Season 1 is now the last under the current format. Token claims end on July 7, 2026, and any tokens not claimed by that date will be forfeited and no longer available.
The overhaul reflects a broader effort by Chainlink Labs to draw a tighter connection between network revenue and $LINK token value, moving away from indirect incentives through third-party project distributions.
Sources:
Chainlink Blog: Build Program Evolution
Chainlink Blog: Introducing Chainlink Rewards Season 1
Chainlink Blog: Introducing the Chainlink Reserve
Akcionáři Select Medical schválili převzetí konsorciem vedeným Robertem A. Ortenziem, Martinem F. Jacksonem a Welsh, Carson, Anderson & Stowe (WCAS). Uzavření transakce se čeká v polovině roku 2026.
, /PRNewswire/ -- Select Medical Holdings Corporation (NYSE: SEM) ("Select Medical," "we," "us," or "our") confirmed today that its previously announced Agreement and Plan of Merger (the "Merger Agreement," and the transaction contemplated thereby, the "Merger") with an entity affiliated with a consortium led by Robert A. Ortenzio, Executive Chairman, Co-Founder and Director of Select Medical, Martin F. Jackson, Senior Executive Vice President of Strategic Finance and Operations of Select Medical, and Welsh, Carson, Anderson & Stowe ("WCAS" and, together with Mr. Ortenzio and Mr. Jackson, the "Consortium") was approved at a special meeting of Select Medical's stockholders (the "Special Meeting") on June 26, 2026. The closing of the Merger remains subject to the terms and conditions of the Merger Agreement, as described more in detail in the Definitive Proxy Statement on Schedule 14A (the "Definitive Proxy Statement"), filed with the U.S. Securities and Exchange Commission (the "SEC") on May 19, 2026. Subject to those terms and conditions, Select Medical expects that the closing of the Merger will occur mid-2026.
Approximately 82.54% of Select Medical's outstanding shares were voted at the Special Meeting, and the Merger was approved by over 79.88% of Select Medical's outstanding shares and over 76.64% of the outstanding shares held by stockholders unaffiliated with the Consortium. Select Medical will file the final voting results in a Current Report on Form 8-K with the SEC.
Advisors
J.P. Morgan and Wells Fargo are serving as joint lead arrangers and joint lead bookrunners in connection with the committed debt financing of the Consortium. Goldman Sachs is serving as the exclusive financial advisor, and Skadden, Arps, Slate, Meagher & Flom LLP is serving as legal counsel to the Special Committee of disinterested and independent directors of the Board of Directors of the Company. Dechert LLP is serving as legal counsel to Select Medical. Wells Fargo and J.P. Morgan are serving as financial advisors, and Cravath, Swaine & Moore LLP is serving as legal counsel to the Consortium. Barclays is serving as financial advisor, and Ropes & Gray LLP is serving as legal counsel to WCAS. Paul Hastings LLP is serving as legal counsel to the debt financing sources.
About Select Medical
Select Medical is one of the largest operators of critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation clinics in the United States based on number of facilities. Select Medical's reportable segments include the critical illness recovery hospital segment, the rehabilitation hospital segment, and the outpatient rehabilitation segment. As of March 31, 2026, Select Medical operated 103 critical illness recovery hospitals in 28 states, 41 rehabilitation hospitals in 15 states, and 1,912 outpatient rehabilitation clinics in 37 states and the District of Columbia. At March 31, 2026, Select Medical had operations in 38 states and the District of Columbia. Information about Select Medical is available at www.selectmedical.com.
About WCAS
WCAS is a leading U.S. private equity firm focused on two target industries: technology and healthcare. Since its founding in 1979, the firm's strategy has been to partner with outstanding management teams and build value for its investors through a combination of operational improvements, growth initiatives, and strategic acquisitions. The firm has raised and managed funds totaling over $33 billion of committed capital. For more information, please visit www.wcas.com.
This release contains forward-looking statements. Forward-looking statements use words such as "expect," "anticipate," "outlook," "intend," "plan," "confident," "believe," "will," "should," "would," "potential," "positioning," "proposed," "planned," "objective," "likely," "could," "may," and words of similar meaning, as well as other words or expressions referencing future events, conditions or circumstances. Statements that describe or relate to Select Medical's plans, goals, intentions, strategies, financial outlook, are examples of forward-looking statements. Forward-looking statements are based on our current beliefs, expectations and assumptions, which may not prove to be accurate, and involve a number of known and unknown risks and uncertainties, many of which are out of Select Medical's control. Forward-looking statements are not guarantees of future performance and you should not place undue reliance on Select Medical's forward-looking statements. Forward-looking statements involve significant known and unknown risks and uncertainties that may cause Select Medical's actual results in future periods to differ materially from those projected or contemplated in the forward-looking statements. The inclusion of such statements should not be regarded as a representation that such plans, estimates or expectations will be achieved. There is no assurance that the proposed Merger will be consummated, and there are a number of risks and uncertainties that could cause actual outcomes and results to differ materially from the results contemplated by such forward-looking statements, including, without limitation: (1) the inability to consummate the proposed Merger within the anticipated time period, or at all, due to any reason, including the failure to obtain any required regulatory approvals for the proposed Merger or the failure to satisfy the other conditions to the consummation of the proposed Merger; (2) the risk that the proposed Merger disrupts Select Medical's current plans and operations or diverts management's attention from its ongoing business; (3) the effect of the announcement of the proposed Merger and results of the Special Meeting on the ability of Select Medical to retain and hire key personnel and maintain relationships with those with whom it does business; (4) the effect of the announcement or pendency of the proposed Merger on Select Medical's operating results and business generally; (5) the significant costs, fees and expenses related to the proposed Merger; (6) the risk that Select Medical's stock price may decline significantly if the proposed Merger is not consummated; (7) the nature, cost and outcome of any litigation and other legal proceedings, including any such proceedings related to the proposed Merger and instituted against Select Medical and/or their respective directors, executive officers or other related persons; (8) other risks that could affect Select Medical's business, financial condition or results of operations, including those set forth in the Company's most recent Annual Report on Form 10-K and any subsequent filings; and (9) other risks to the consummation of the proposed Merger. Additional information concerning these and other factors can be found in Select Medical's filings with the SEC, including Select Medical's most recent annual report on Form 10-K. Select Medical does not undertake any obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
THORChain je po zhruba měsíci opět online a znovu umožňuje swapy. Monero se v v3.19.2 přiblížilo mainnetu, ale první obchody mají být malé kvůli mělké likviditě.
THORSday Community Podcast #211 ft. CBarraford, KentonC137 & Patriotsounds | June 25, 2026 | Watch the full episode on YouTube
By Raynalytics
TL;DRTHORChain trading is back after roughly a month offline. The team framed the recovery as one of the harder classes of incidents to debug, but the network is live again and the roadmap can move.$XMR moved closer. v3.19.2 includes the Solana churn fix and embeds Monero code, with Chad saying $XMR could land closer to two weeks after trading resumed than the month previously discussed.The security path is becoming clearer: publish the TSS library around v3.20, keep reviewing the GG20 patch surface with Huginn and Soda Labs, then move chain by chain toward DKLS and FROST.Growth work did not stop during the pause. Morpheus, Keplr Wallet, affiliate onboarding, KOL campaigns, x402 payments and MCP tooling all came up as ways to make THORChain more reachable.POL became the biggest governance topic. The debate is now about how aggressively THORChain should route income into protocol-owned liquidity, especially if Monero needs deep pools quickly.1. Trading Is Back, and the Roadmap Can Breathe AgainDenny opened the first post-restart THORSday like a man who had been waiting a month to press the party button. Confetti fired, the desk-pop jokes landed, and the simple message was the one everyone wanted to hear: THORChain is back online and swapping again.
Under the celebration, Chad Barraford kept the explanation grounded. This was not a normal bug hunt where a developer can read logs, isolate a bad branch and patch the issue within hours. The exploit lived in peer-to-peer validator communication and key-share behavior, which meant the team had to infer the attack path from limited evidence and then make sure the thing they found was the thing that mattered.
"This kind of attack is one of the hardest to recover from." (Chad)That is why the restart took as long as it did. The network had to recover from a sophisticated cryptography attack, deal with verification and node issues along the way, and then get back into a state where the team could safely resume trading. Now that it has, Chad's posture was simple: the team can get back to the roadmap.
For users, the practical message is equally simple. Swaps are back through THORChain Swap, and the ecosystem has breathing room again. For the dev side, the next release is already queued.
2. Monero Moves From "Later" to "Soon"The biggest roadmap update was Monero. Chad said v3.19.2 is being cut with two important pieces: a fix for a Solana churn issue, and the Monero integration embedded in the release. The $XMR code still needs more internal testing and node readiness, but the tone changed from "roughly a month after restart" to "closer to two weeks."
The caveat matters. Nodes still need to build and sync Monero infrastructure, which Chad estimated around two to three days depending on resources. He also said there is a chance Zcash and Monero could launch together, but he did not frame that as a promise.
Denny tied the moment back to the privacy thesis. For the first time, Monero holders would get permissionless layer 1 to layer 1 access without bridges, wrapped assets, accounts or KYC. He also made sure nobody mistook that excitement for a guarantee of a perfect launch.
"The pools will be shallow. Do not attempt big swaps at first." (Denny)That warning should be repeated. Mainnet is different from testnet. New chain clients have always had their own quirks, and Monero is the most complex chain THORChain has added. The likely launch path is small swaps first, close monitoring and a willingness to pause if something behaves badly.
The shout-outs were important too. Boone started the Monero chain-client process, and Luke Parker's work through Serai gave THORChain an open-source FROST TSS base that helped make the integration possible. Testing never fully stopped during the trading pause. The work just moved in the background until the network could breathe again.
3. Security: Open Source, Huginn, DKLS and FROSTSecurity dominated the technical section. The current TSS library is not public yet, but Chad expects it to be open sourced around v3.20, likely after a deeper Soda Labs review. Soda Labs is still spending time with the codebase before the team opens it again, and Chad framed that delay as a tradeoff in favor of better review.
The review surface is not small. Chad said Huginn, his AI audit and triage agent, has opened close to 200 issues against the private TSS library alone, with varying severity. The team is reviewing and prioritizing them, but not every issue necessarily deserves a patch if the long-term plan is to leave GG20.
"Everybody wants to get off of GG20 and move to DKLS." (Chad)That does not mean pressing a panic button. Chad emphasized that changing cryptography is inherently dangerous, especially when live funds have to migrate between schemes. The likely path is slower and more controlled: move chain by chain, start with smaller-value chains if possible, observe keygen and signing behavior, then expand.
The direction is now a dual track. Use FROST where THORChain can, especially EVM chains and Bitcoin through Taproot. Use DKLS where FROST is not available, such as Litecoin and Dogecoin. Monero already uses FROST, but Chad clarified that it is a different variant and cannot simply be reused for EVMs or Bitcoin.
Chainflip came up as one possible FROST implementation to study because it has been in production, but Chad made no commitment. THORChain still needs to evaluate whether any candidate library supports the accountability features the protocol needs, including identifying and slashing participants who hold up keygen or signing.
The team is also exploring bigger vault architecture ideas: hot and cold vaults, less frequent signing for most funds, and possibly two-of-two schemes later. The security team has a deeper meeting next Wednesday. Chad suggested next THORSday may have a clearer readout.
4. The Growth Stack: Wallets, KOLs and AI AgentsThe pause did not freeze business development. Kenton ran through a stack of smaller but important growth items now that trading is live again.
First, Morpheus. THORChain had a call with Morpheus, the decentralized AI project, and the immediate next step is simple: whitelist the ERC20 contract so a liquidity pool can be created. David from Morpheus is expected on the podcast in August. Kenton also floated the broader idea of reaching out to more ERC20 communities that want access to Bitcoin liquidity without asking nodes to support a whole new chain.
Second, wallets and affiliates. Keplr Wallet support on THORChain Swap is expected to start with EVM chains, then UTXO chains. The affiliate page is also being cleaned up so partners can get API keys, set fees, choose payout assets and likely create a THORName up front as part of the onboarding flow.
Third, marketing. Eric from Moca introduced Kenton to Creatorverse, the campaign platform from SCAL3. The pitch is a contest model for KOLs: creators compete on a leaderboard, with payouts tied to performance instead of a flat fee per post. Kenton liked the game theory, while Chad immediately asked the right question: how do they keep bots from gaming likes and retweets?
The AI-agent section was the most forward-looking. After the Morpheus call, Chad listed action items around x402 payments, Ethereum agent standards and an MCP for THORChain. He has built an MCP before and said he may open source it. Andy from Liquify has also been working on MCP tooling.
Kenton had already started checking THORChain's web properties with Agents First, trying to make thorchain.org and THORChain Swap easier for AI systems to read and interact with.
"THORChain has to be easily accessible by AI." (Kenton)The thesis is straightforward: if agents become a major share of blockchain transactions, THORChain cannot be invisible to them.
5. POL Takes Center StageThe biggest governance conversation was protocol-owned liquidity. With trading back and Monero close, Kenton wanted to know when the community should start debating what percentage of system income should go to POL.
The first issue is mechanics. Chad believed the POL percentage had been moved to an operational Mimir, where nodes can vote different percentages and the leading value wins. Boone joined to say his dashboard still shows it as an economic Mimir, with 12 votes trying to set it to 1%. Chad linked the commit he remembered making and said he would need to check whether something had been reverted.
The second issue is economics. Kenton corrected his own math from a previous discussion: if the system moved from 75% of fees going to nodes to 50% going to nodes and 25% going to POL, node operators would need to raise operator fees by 50% to get back to even. His view was that bond providers and operators need to have that conversation honestly, especially in a lower-fee, lower-$RUNE environment.
Boone's argument was urgency. After the exploit, asking third-party LPs to trust the pools immediately is a hard sell. Monero could become one of THORChain's most important pools, but without POL, the liquidity has to come from somewhere else.
"Getting liquidity back into the pools is a really really huge priority." (Boone)That is why the POL debate feels bigger than a simple fee split. Under normal LP incentives, THORChain rents liquidity from third parties and keeps paying for it. Under POL, the protocol slowly owns more of the pools, earns fees on its own liquidity and can target liquidity into strategic pools like $XMR.
"It's renting versus owning." (Boone)Kenton floated 25% POL while keeping the 5% $RUNE burn, or 29% POL with the burn reduced to 1%. Denny preferred going as aggressive as possible, while keeping at least a 1% burn for the deflationary narrative. The hosts also noted that the attack aftermath already left several million $RUNE to burn, far more than the fee-burn mechanism had destroyed so far, though they were careful with the exact number.
The sales pitch for new chains may be even stronger. Instead of paying a centralized exchange listing fee and handing supply to a market maker that sells, a project can seed a THORChain pool, keep custody of its LP position, accept impermanent loss as the real cost, and let POL keep buying and holding its token if the pool earns its way there. That turns THORChain from a listing venue into a long-term liquidity partner.
What to Watchv3.19.2 adoption. Watch for the Solana churn fix, Monero code adoption and node readiness after the release reaches operators.$XMR mainnet. The target moved closer, but shallow liquidity and possible early pauses should be expected. Small swaps first.The security meeting. Next Wednesday's discussion may clarify hot/cold vaults, two-of-two ideas and the first DKLS or FROST migration path.v3.20. Chad expects the public TSS library around v3.20, with $TAO and free stable swaps also discussed for that release path, gated by Mimir where needed.POL governance. The Mimir type needs clarity, then the community has to converge on a percentage. The practical question is how fast THORChain should own liquidity again.AI accessibility. x402, MCP tooling and agent-readable THORChain sites are now explicit action items, not abstract future talk.Upcoming guest. Saturday's episode is expected to feature Amir Taaki for the Monero and cypherpunk crowd.More THORChain data, check out raynalytics.net
Follow Raynalytics for more Weekly Analytics and Podcast recaps.
Sunrise DeFi spustila na Solaně tokenizovanou verzi Roundhill Memory ETF s tickerem $DRAM. Obchoduje se na Jupiteru a přináší expozici na paměťové čipy přímo do DeFi.
You can now trade a memory-chip ETF from your Solana wallet. Sunrise DeFi, a platform built by Wormhole Labs, has launched a tokenized version of the Roundhill Memory ETF, ticker $DRAM, on Solana’s Jupiter exchange.
What $DRAM actually is The underlying asset here is the Roundhill Memory ETF, which trades on traditional markets under the Cboe BZX exchange with the ticker DRAM. That fund launched on April 2, 2026, and quickly attracted billions in assets under management as AI-driven demand for memory chips accelerated.
Advertisement
Sunrise DeFi’s contribution is wrapping that ETF into a token that lives natively on Solana. The $DRAM token is now live on Jupiter, Solana’s dominant decentralized exchange aggregator, which handles swaps and lending across the ecosystem. This isn’t Sunrise DeFi’s first rodeo. The platform has previously handled the integration of PAX Gold (PAXG) and Ethena’s ENA token on Solana, building a track record of ensuring liquidity from day one for newly tokenized assets.
The bigger picture: tokenized equities flood Solana $DRAM isn’t arriving in isolation. It’s part of a broader wave of tokenized traditional financial products landing on Solana throughout 2026. Ondo Global Markets and Securitize are among the firms actively working to bring tokenized equities and funds to the network. Jupiter has become the natural landing pad for these products, serving as the connective tissue between tokenized real-world assets and Solana’s existing DeFi ecosystem.
Sunrise DeFi, designed specifically by Wormhole Labs to facilitate these integrations, is positioning itself as the go-to bridge between traditional finance products and Solana’s DeFi rails. Wormhole’s cross-chain messaging infrastructure gives it a natural advantage here, since moving assets across ecosystems is literally what the protocol was built for.
What this means for investors Tokenized ETFs remove several friction points from traditional investing. No brokerage account needed. No market hours. No T+1 settlement.
For memory-chip bulls specifically, $DRAM offers a way to express that thesis entirely within the DeFi ecosystem. Instead of holding the ETF in a brokerage and crypto in a separate wallet, traders can now manage both exposures in a single interface. That composability—the ability to use $DRAM as collateral for loans or pair it in liquidity pools—is where tokenized assets genuinely differentiate themselves from their traditional counterparts.
Disclosure: This article was edited by Editorial Team. For more information on how we create and review content, see our Editorial Policy.
Krypto ETF za 30 dní ztratily asi 5 miliard USD, protože odlivy zasáhly Bitcoin, Ethereum, Solanu i XRP. Spotové Bitcoin ETF v USA zaznamenaly největší denní odliv v červnu, 696,29 milionu USD.
Institutional demand for cryptocurrency ETFs weakened sharply this week as investors pulled billions of dollars from products tied to Bitcoin, Ethereum, Solana, and XRP. The latest wave of redemptions coincided with Bitcoin falling below $60,000, marking one of the most challenging periods for crypto investment products since the launch of spot ETFs in the United States.
US-listed spot Bitcoin ETFs recorded their largest daily net outflow in June on Thursday, while Solana ETFs are headed toward their first monthly net outflows on record. Across the broader market, crypto ETFs have collectively lost approximately $5 billion over the past 30 days, highlighting a widespread shift in investor sentiment.
Bitcoin ETFs post June's biggest outflow According to SoSoValue data, US spot Bitcoin ETFs recorded net outflows of $696.29 million on Thursday, surpassing the previous monthly high of $519.2 million recorded on June 2. The latest withdrawals extended Bitcoin ETF outflows to 6 consecutive trading days.
June has now recorded total net Bitcoin ETF outflows of $3.61 billion, while year-to-date net outflows have reached $4.56 billion. Since the beginning of May, investors have withdrawn approximately $6.04 billion from spot Bitcoin ETFs.
The selling pressure also appeared concentrated among the industry's largest funds. Fidelity's FBTC recorded $274 million in net outflows on Thursday, while BlackRock's IBIT lost another $265 million. The previous trading session on June 24 had already seen another $469.08 million leave US spot Bitcoin ETFs. The outflows have significantly reduced the size of the US Bitcoin ETF market.
SoSoValue data shows that total net assets across US-listed spot Bitcoin ETFs have fallen below $73 billion for the first time since late 2024. Combined assets now stand at approximately $72.57 billion. The decline represents a substantial drop from the sector's peak of $169.5 billion reached in October 2025, leaving total assets approximately 57% below their record highs.
More recently, total Bitcoin ETF assets have fallen from $104.29 billion on May 15 to $72.57 billion, extending a 7-week decline. Bitcoin ETF assets now represent 6.09% of Bitcoin's circulating market capitalization, down from more than 7% during the May peak.
Solana ETFs Record Their Worst-Performing Month Solana investment products also experienced notable weakness. June is on track to become the worst month on record for US spot Solana ETFs, with the category posting its first monthly net outflows. Net redemptions currently total $5.80 million for the month. On Thursday alone, Solana ETFs lost $3.94 million, with all of the outflows coming from Bitwise's $BSOL fund.
Ethereum products also joined the broader selling trend. Spot Ether ETFs recorded combined net outflows of $81.87 million, with BlackRock's $ETHA accounting for $62.99 million of the withdrawals. XRP ETFs remained flat during Thursday's session, recording neither net inflows nor net outflows.
While other Hyperliquid-related investment products experienced withdrawals, Grayscale's $HYPG fund stood out as the sole major crypto ETF to record net inflows, drawing in $112.73 million. This positive momentum was primarily the result of Hyper Holdings providing the fund with seed capital in the form of 2 million $HYPE tokens.
Bitcoin falls below $60,000 The ETF selling coincided with another sharp decline in cryptocurrency prices. Yesterday, Bitcoin briefly fell to $58,050, its lowest level since October 2024, before recovering to around $60,000. The recent market weakness has been linked to concerns surrounding Strategy and its $STRC preferred shares, which declined further to a new all-time low of $72 earlier today.
Solana also came under heavy pressure during the broader market sell-off, briefly dropping to $64 before leading the recovery among majors with an over 10 % rise in the last 24 hours.
Will The Sentiment Remained Subdued? Market observers continue to view ETF flows as an important measure of institutional demand. Citi has previously described Bitcoin ETF flows as one of the best indicators of investor adoption and expects sentiment to remain subdued while ETF flows stay negative.
In a recent report, CoinShares noted that Bitcoin's recovery from approximately $58,000 indicates continued buying interest during market declines, although resistance around $60,000 remains significant. The firm also observed that whale selling, which contributed heavily to the October market decline, has slowed considerably. However, the firm cautioned that whales historically do not return as consistent buyers until the next Bitcoin halving cycle, which is expected in 2028.
Looking ahead, CoinShares expects market conditions to remain challenging as inflation concerns, elevated oil prices, and a hawkish Federal Reserve continue to weigh on risk assets. The firm also believes delays in passing the CLARITY Act could extend uncertainty about the US regulatory environment, with the legislation now more likely to advance toward the August congressional recess than in early July.
For now, persistent ETF outflows across nearly every major cryptocurrency suggest institutional investors remain cautious as falling prices, macroeconomic uncertainty, and concerns surrounding Strategy continue to pressure digital asset markets.
Read More on SolanaFloor Solmate Board Under Scrutiny Over Alleged $18M Dilution of Shareholder Value
26 Solana Frontier Winners Revealed After Crypto’s Biggest Hackathon Ever
dLocal byla zařazena do indexu Russell 2000® a automaticky i do příslušných růstových indexů. Změna vstoupí v platnost při otevření amerického trhu 29. června.
MONTEVIDEO, Uruguay, June 26, 2026 (GLOBE NEWSWIRE) -- DLocal Limited (“dLocal”, “we”, “us”, and “our”) (NASDAQ:DLO), a leading cross-border financial infrastructure platform connecting global merchants to emerging markets, today announced that the Company was added as a member of the US small-cap Russell 2000® Index, effective when the US market opens on June 29 as part of the 2026 Russell indexes reconstitution. Membership in the Russell 2000® Index is based on membership in the broad-market Russell 3000® Index. The stock also was automatically added to the appropriate growth indexes.
“Inclusion in the Russell 3000® and Russell 2000® Indexes marks an important milestone for dLocal and reinforces the growing institutional recognition of our platform, our scale, and our continued execution across emerging markets. We believe this inclusion also reflects the scale, market capitalization, and free float we have built as a public company, and will help broaden our shareholder base, improve trading liquidity, and increase visibility among institutional investors as we continue building the financial infrastructure that connects global enterprises to the markets of the future,” said Pedro Arnt, CEO of dLocal.
Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies. According to data as of the end of June 2025, about $12.2 trillion in assets are benchmarked against the Russell US indexes, which belong to FTSE Russell, the global index provider.
For more information on the Russell 2000® Index and the Russell indexes reconstitution, go to the “Russell Reconstitution” section on the FTSE Russell website.
About dLocal
dLocal builds financial infrastructure for markets of the future, connecting global enterprises with billions of emerging market consumers in more than 60 countries across high-growth markets in Africa, Asia, the Middle East, and Latin America. Through the “One dLocal” concept (one direct API, one platform, and one contract), global companies can accept payments, send payouts, and settle funds globally without the need to manage multiple local entities and integrations. For more information, visit www.dlocal.com.
About FTSE Russell, an LSEG Business
FTSE Russell is a global index leader that provides innovative benchmarking, analytics and data solutions for investors worldwide. FTSE Russell calculates thousands of indexes that measure and benchmark markets and asset classes in more than 70 countries, covering 98% of the investable market globally. FTSE Russell index expertise and products are used extensively by institutional and retail investors globally.
Approximately $21.20 trillion is benchmarked to FTSE Russell indexes. Leading asset owners, asset managers, ETF providers and investment banks choose FTSE Russell indexes to benchmark their investment performance and create ETFs, structured products and index-based derivatives.
A core set of universal principles guides FTSE Russell index design and management: a transparent rules-based methodology is informed by independent committees of leading market participants. FTSE Russell is focused on applying the highest industry standards in index design and governance and embraces the IOSCO Principles. FTSE Russell is also focused on index innovation and customer partnerships as it seeks to enhance the breadth, depth and reach of its offering.
FTSE Russell is wholly owned by LSEG. For more information, visit FTSE Russell.
Forward Looking Statements
This press release contains certain forward-looking statements. These forward-looking statements convey dLocal’s current expectations or forecasts of future events. Forward-looking statements regarding dLocal involve known and unknown risks, uncertainties and other factors that may cause dLocal’s actual results, performance or achievements to be materially different from any future results, performances or achievements expressed or implied by the forward-looking statements. Certain of these risks and uncertainties are described in the “Risk Factors,” and “Cautionary Note Regarding Forward-Looking Statements” sections of dLocal’s filings with the U.S. Securities and Exchange Commission. Unless required by law, dLocal undertakes no obligation to publicly update or revise any forward-looking statements to reflect circumstances or events after the date hereof.
Investoři stáhli z burz více než 300 miliard SHIB a exchange rezervy klesly na 80,37 bilionu. Netflow zůstal záporný na -355,54 miliardy SHIB, což ukazuje na další akumulaci.
Despite Shiba Inu’s recent price weakness, investors have resumed accumulating the token, withdrawing more than 300 billion SHIB from exchanges over the past 24 hours.
Notably, Shiba Inu’s exchange reserve have retreated from recent highs, signaling renewed accumulation activity. The metric, which tracks the amount of SHIB held in exchange wallets, fell from approximately 80.5 trillion tokens to 80.37 trillion in less than 48 hours.
Recent Exchange Inflows Interrupted a Multi-Week Trend Before this week’s developments, Shiba Inu’s exchange reserves had been declining steadily for several weeks and had even fallen below the 80 trillion SHIB mark.
However, the trend briefly reversed earlier this week when investors transferred large amounts of SHIB to exchanges, according to data from CryptoQuant. Approximately 749 billion SHIB flowed into trading platforms, pushing exchange reserves to 80.53 trillion on June 23 and further to 80.55 trillion the following day.
Investors Return to Accumulation Contrary to expectations, exchange reserves failed to rise further as SHIB’s price plunged. Instead, they resumed their decline, dropping to 80.37 trillion tokens by press time.
The reversal suggests that many investors have returned to accumulation despite the broader market downturn. In particular, some holders appear to view current price levels as an opportunity to increase exposure rather than reduce positions.
SHIBA INU Exchange Reserve All Exchanges Negative Netflows Strengthen the Bullish Accumulation Case Exchange netflow data further reinforces the accumulation narrative. The metric, which measures the difference between exchange inflows and outflows, has turned negative and currently stands at -355.54 billion SHIB, representing a 2.12% decline in exchange balances over the past 24 hours.
Although inflows surged to 442.21 billion SHIB during the period, outflows significantly exceeded that figure and reached 797.76 billion tokens. As a result, exchanges recorded a net outflow of more than 355 billion SHIB, highlighting continued investor accumulation despite the recent correction.
Shiba Inu Flows to Exchanges Liquidation Wipes Out Over $200K Shiba Inu Leveraged Bets The latest accumulation trend emerged as Shiba Inu experienced another sharp decline that briefly pushed the token to around $0.0000040 earlier today. SHIB later recovered part of its losses and rebounded to approximately $0.0000042.
Nonetheless, the sell-off inflicted heavy losses on leveraged traders. According to liquidation data from CoinGlass, SHIB derivatives traders lost approximately $210,820 over the past 24 hours.
Long traders absorbed the overwhelming majority of the losses, with liquidations approaching $194,000. Meanwhile, short traders recorded comparatively smaller losses totaling about $16,870.
Shiba Inu liquidation DisClamier: This content is informational and should not be considered financial advice. The views expressed in this article may include the author's personal opinions and do not reflect The Crypto Basic opinion. Readers are encouraged to do thorough research before making any investment decisions. The Crypto Basic is not responsible for any financial losses.
Mark Zuckerberg chce, aby Meta prozkoumala spolupráci s Polymarket a Kalshi, zatímco vyvíjí vlastní predikční aplikaci Arena. Ta má používat body místo reálných sázek.
People walk behind a logo of Meta Platforms company, during a conference in Mumbai, India, September 20, 2023. REUTERS/Francis Mascarenhas Purchase Licensing Rights, opens new tab
June 26 (Reuters) - Meta (META.O), opens new tab CEO Mark Zuckerberg has urged his lieutenants to explore partnerships with the popular prediction markets Polymarket and Kalshi as his company builds a similar app, the New York Times said on Friday, citing three employees with knowledge of the matter.
Meta and Kalshi did not immediately respond to requests for comment, while Polymarket declined to comment when contacted by Reuters. Reuters could not independently verify the report.
Get a daily digest of breaking business news straight to your inbox with the Reuters Business newsletter. Sign up here.
The social media company's executives have said Arena, Meta's new prediction market app under development, will differ from Polymarket and Kalshi, which accept real-money wagers, because it will instead rely on video-game-like "points", the report said.
Prediction markets surged in popularity during the 2024 U.S. presidential election and have evolved into an asset class that lets investors wager on a variety of events, from monetary policy to sports tournaments.
But they have also drawn increasing scrutiny as well-timed trades ahead of U.S. President Donald Trump's major policy surprises have potentially led to millions of dollars in profits for unknown traders.
Zuckerberg's target demographic for Arena is 18- to 34-year-olds and Meta is aiming to reach at least 100 million monthly active "predictors" for the app, according to the report.
Arena is being tested internally and may not be released, the report said, adding that Meta plans to eventually integrate parts of Arena into Facebook and Messenger.
The Times first reported on Tuesday that Zuckerberg recently dispatched a small team at his company to create a smartphone app similar to Polymarket and Kalshi.
Reporting by Jaspreet Singh in Bengaluru; Editing by Vijay Kishore
Our Standards: The Thomson Reuters Trust Principles., opens new tab
Google tlačí vydavatele do nového programu AI: za propagaci v AI Overviews chce širší přístup k jejich obsahu včetně tréninku modelů. Kdo nepřistoupí, může přijít o platby z programu Showcase.
Google is reportedly looking to bleed publishers yet again — threatening to exclude them from a lucrative new artificial-intelligence partnership unless they allow the tech giant to train its AI bots on their valuable content.
In recent months, Google has been pitching news and entertainment publishers on a new pilot program that would promote their content in Google’s AI Overviews – a big boost to organizations that have faced significant declines in web traffic, the Information reported.
But in exchange, Google wants broad access to the publishers’ content, including the right to potentially use it to train AI bots, a person familiar with the project told the Information.
Google is reportedly taking a tough stance in negotiations with publishers. SOPA Images/LightRocket via Getty Images Google, which launched its Gemini chatbots in 2023, is driving a hard bargain.
It warned publishers that if they don’t agree to the new program, they will eventually lose out on payments from the current content-licensing arrangement, known as Showcase. Showcase is being ended, Google reportedly told some companies.
“This is Google’s game. They’re gonna dominate here,” said Jason Kint, chief executive of Digital Content Next, a trade group that represents online publishers including the New York Times, the Washington Post and News Corp, The Post’s owner.
“There’s no fair deal discussions that can happen with Google. It’s really a matter of how much money they want to drop on an individual organization,” Kint told The Post.
A spokesperson for Google told The Post: “As people’s news preferences change, we’ve been expanding our partnerships through our News AI pilot program, working with a wide range of publishers to explore how AI can drive more engaged audiences.”
The spokesperson added that Google has been “testing features” to “help people cut through information overload, easily decide where to click out, and connect with news in different formats.”
Publishers have complained that traffic to their websites from search results has already plummeted – some by as much as half – since Google launched its AI Overview tool in 2024, which supplies an AI-generated summary of search results at the top of the page.
A Pew Research Center study found that when people see an AI Overview, they are half as likely to ever click a link from Google, and when they find an answer in an AI Overview, they are more likely to end their browsing session altogether.
Google CEO Sundar Pichai visits the company’s new AI hub in France on Feb. 15, 2024. REUTERS Google has said it continues to send billions of clicks to websites every day and that the Pew study’s methodology was flawed.
One year after Google launched its AI Overview tool to the public, CNN saw traffic to its website fall by 30%, while Business Insider and HuffPost’s sites saw traffic plunge about 40%, according to an NPR report citing data from Similarweb.
That is a big hit to news publishers, who are heavily dependent on advertising – which is tied to how many clicks they can drive to their website – as well as audience revenue streams, like subscriptions and other paywalls.
Meanwhile, several publishers have filed lawsuits accusing tech companies of scraping data from their sites for use in training their AI bots – which has sent AI giants racing to secure content-licensing agreements.
Google launched its Gemini chatbots in 2023. Ai – stock.adobe.com In 2023, the New York Times sued OpenAI and Microsoft, alleging the ChatGPT-maker had stolen content from its website to train its AI models.
OpenAI has since signed more than a dozen content-licensing deals with news and entertainment publishers.
Kint said tech giants have been holding the reins in these discussions — Google controls 90% of the search-engine market and was ruled a monopoly in a landmark antitrust case in 2024.
Google asked a federal appeals court to reverse the decision in May.
Google is reportedly seeking broader access to use content to train its AI bots. prima91 – stock.adobe.com The company first announced the new AI pilot program in December, with initial partners including the Washington Post and the Guardian.
“They bundled the opt-out from AI training with the Search opt-out. So publishers, if they wanted to say, ‘Hey, you can’t train on my content for AI Overviews,’ then they had to opt out of Search,” Kint told The Post.
“If you’re opting out of Search, then you’re opting out of the internet.”
Publishers that currently participate in Google’s Showcase program, which highlights their content across Google News features, receive a flat annual fee.
If partners do not sign on to the new pilot program, they will continue to receive annual payments as long as Showcase remains in place, but these will end if the program does, according to the Information.
Google said it has been renewing Showcase agreements.
Those who sign up for the new pilot will be agreeing to broader content-use terms for the same flat annual fee, which is giving some publishers pause, the Information reported.
Shares of UnitedHealth Group (UNH +2.87%) are up 25% this year and are still trading near its 52-week high. The healthcare giant's stock offers a good combination of revenue growth, a solid dividend, and strong insulation against economic downturns.
The company has bounced back significantly after it had a bad earnings miss and suspended guidance in April 2025, a move that was followed by the resignation of then-CEO Andrew Witty.
Here are reasons why the stock remains a good buy.
Image source: Getty Images.
It's a great dividend stock UnitedHealth Group just raised its dividend by 5% to $2.32 per quarterly share, marking 17 consecutive years of raises, and at the stock's current price, it yields around 2.3%.
The dividend increase shows the company is confident in its ability to handle rising medical costs and other changes. The company produced $19.7 billion in operating cash flow in 2025, equal to 1.5x net income. Cash from operations has consistently exceeded net income.
The stock is a solid choice for total-return and income-focused investors. The company generates massive, highly reliable free cash flow that supports aggressive share buybacks, as it expects to repurchase $2 billion in shares by the end of the second quarter and to maintain a consistently growing dividend.
Today's Change
(
2.87
%) $
11.94
Current Price
$
427.47
Two segments balance the business Unlike pure-play health insurers, UnitedHealth Group operates a highly resilient, diversified model split into two powerhouse segments. One is UnitedHealthcare, its huge insurance arm that served 49.1 million people in the first quarter, including individuals, employers, and government programs.
The other is Optum, its health services business that provides pharmacy benefits, data analytics, and direct patient care to more than 123 million people.
In the first quarter, the UnitedHealthcare side was driving its business. The company reported overall revenue of $111.7 billion, up 2% year over year, with UnitedHealthcare reporting $86.3 billion, up 2% from the first quarter of 2025. Earnings per share (EPS) were $6.90, up less than 1% compared to the same period a year ago, and earnings from UnitedHealthcare again were the catalyst, with earnings from operations of $5.7 billion, up 9%, year over year.
It is still selling at an attractive valuation Though UnitedHealth Group's shares have risen more than 25% this year, its shares are still trading at around 31 times earnings and around 22 times future earnings.
The advantage of healthcare stocks is that people need medical care regardless of the state of the economy. Concerns about rising costs combined with no reimbursement raises on the way for 2027 have compressed the company's valuations into reasonable territory compared to its historical averages and put it in a good position compared to its nearest competitors.
It has strong pricing power that reacts to change UnitedHealth Group's medical cost ratio was 83.9% for the first quarter, down 90 basis points from the same period a year ago. That's the good news. The bad news is that medical cost ratios have been increasing for insurers over the past several years, due to changes under the Affordable Care Act, the rising number of older adults seeking medical care, the rising costs of diabetes and weight-loss medications, and medical advancements tied to high-cost medical devices.
UnitedHealth has a clear playbook for managing the recent industrywide spike in medical utilization. Because commercial plans renew continuously throughout the year, management has already begun implementing a strongly responsive pricing strategy. In its Medicare Advantage plans, the company is adjusting premium pricing, streamlining provider networks, and utilizing advanced tools to filter unnecessary clinical costs. That's a key point because UnitedHealth is the largest Medicare Advantage provider, serving more than 8 million people. In April, CMS finalized a 2.48% payment increase for 2027 Medicare Advantage plans, which was more than what was initially proposed, but doesn't solve long-term price concerns, industry executives said.
The company is using AI to trim administrative costs UnitedHealth Group has launched a massive $1.5 billion enterprise-wide artificial intelligence (AI) initiative. By transitioning traditional, fractured processes to AI-first operations, management expects a 2-to-1 return on investment, translating into nearly $1 billion in direct operating-cost reductions.
The company is deploying artificial intelligence across three core operational fronts to aggressively defend and expand its operating margins. It is using generative AI to handle the first point of contact, reducing the need for expensive call center networks.
Launched in March, its digital companion Avery is a generative AI assistant handling inquiries for employers and Medicare Advantage members. It is set up to resolve complex questions about coverage limits, claim status, and copay estimates instantly. By migrating member navigation to self-service AI, UnitedHealth has already reduced call center volume by 25% as of the first quarter, eliminating significant structural overhead.
It is also using AI to simplify and speed up prescription approval times from eight hours to under 30 seconds and considerably drop processing costs. The company sees its AI engine as not only saving money but also, when outsourced, adding revenue.
About a third of UNH's $1.5 billion AI spend is dedicated to transforming OptumInsight into an AI-first software firm. The data analytics, payment integrity, and fraud-detection models trained internally on UNH's massive data pool are being packaged and sold directly to other hospital networks and insurers, turning an internal cost-saver into a high-margin revenue stream.
Oracle zažila nejhorší týden na Wall Streetu za 25 let, když akcie spadly o 19 % kvůli obavám z dluhu a financování projektů v oblasti AI. Firma má kolem 130 miliard USD dluhu a ve fiskálním roce 2027 plánuje získat 40 miliard USD z dluhu a kapitálu.
Oracle just wrapped up its worst week on Wall Street in 25 years as concerns continue to mount about the software company's debt load and whether its bet-the-house investment on artificial intelligence will pay off.
The stock plummeted 19% this week, dropping at least 2.6% each of the past five days. It's the steepest weekly drop since a 20% plunge in August 2001, during the depths of the dot-com bust.
The past nine months have been brutal for Oracle investors. After the company reached a peak market cap of $900 billion in September, on budding enthusiasm about Oracle's AI customers, the stock has lost about 55% of its value. The crux of the problem is that for Oracle to fulfill its AI infrastructure commitment, primarily to OpenAI, it's having to raise record amounts of debt, creating balance sheet risk while focusing on lower-margin offerings.
Oracle was sitting on about $130 billion in debt at the end of May, with capital expenditures rising 162% to nearly $56 billion in the 2026 fiscal year. It's racing to open data centers alongside cloud giants Amazon, Microsoft and Google, but without being able to sell a full technology stack like its rivals.
Oracle recorded negative free cash flow of almost $24 billion in the latest fiscal year. Earlier this month, Oracle said that, in fiscal 2027, it plans to raise $40 billion through debt and equity financing, including a $20 billion share sale announced earlier, after $43 billion in debt sales and $5 billion from equity issuance last fiscal year.
"We expect financing/leverage and the pace of equity issuance to remain the central investor debate near term, even as demand signals stay strong," Evercore analysts, who recommend buying the stock, wrote in a note on Wednesday note.
Like Evercore, most firms remain bullish on Oracle's prospects despite investors' growing concerns. According to FactSet, 71% of analysts recommend buying the stock, the highest percentage in 15 years.
Oracle didn't respond to a request for comment.
watch now
Oracle is facing multiple market headwinds. In addition to its hefty capital requirements, the company is trading lower from the selloff in software names as investors worry that AI models will replace many of their products' capabilities. The iShares Expanded Tech-Software Sector Exchange-Traded Fund (IGV) is down 16% so far in 2026, while Oracle has fallen 24%.
In its annual report last week, Oracle disclosed that headcount shrank 13% to 141,000 employees in fiscal 2026, with a notable pullback in sales and marketing.
Larry Ellison, Oracle's co-founder, was absent from the earnings call this month, leaving dual CEOs Clay Magouyrk and Mike Sicilia and recently appointed finance chief Hilary Maxson to answer questions.
"Hilary has a tough life," Magouyrk said on the call.
Because of Oracle's retreating stock price, Ellison has been surpassed on the world's list of wealthiest people by Google co-founders Larry Page and Sergey Brin, Amazon founder Jeff Bezos and Michael Dell. Ellison is still worth over $200 billion.
Oracle is pushing forward with its buildout plans, targeting data centers in Michigan, New Mexico and Texas in 2027.
"As we pursue these opportunities, we'll remain focused on disciplined capital allocation, maintaining a strong balance sheet, and preserving our investment-grade credit rating," Maxson said on the earnings call this month.
AbbVie oznámila, že FDA schválila SKYRIZI pro děti od 6 let se středně těžkou až těžkou ložiskovou psoriázou nebo aktivní psoriatickou artritidou. Současně získala schválení i nová 55mg předplněná stříkačka pro pacienty vážící méně než 40 kg.
SKYRIZI (risankizumab-rzaa) is now approved for patients six years of age and older with moderate-to-severe plaque psoriasis or active psoriatic arthritis Approval includes a new 55 mg pre-filled syringe to support weight-based dosing for those patients weighing less than 40 kg SKYRIZI becomes the first and only IL-23 inhibitor approved in the U.S. for pediatric patients six years of age and older weighing less than 40 kg with plaque psoriasis or psoriatic arthritis , /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced the U.S. Food and Drug Administration (FDA) has approved SKYRIZI® (risankizumab-rzaa) for the treatment of children six years of age and older with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy, or active psoriatic arthritis. A new 55 mg pre-filled syringe (PFS) has also been approved to support weight-based dosing for patients weighing less than 40 kg, while the currently available 150 mg PFS and Pen are approved for patients weighing 40 kg or greater.
"Plaque psoriasis and psoriatic arthritis can affect much more than skin and joints – these conditions can shape daily life and disrupt important childhood experiences," said Roopal Thakkar, M.D., executive vice president, research and development, chief scientific officer, AbbVie. "We are proud that SKYRIZI is now the first and only IL-23 inhibitor approved in the U.S. for pediatric patients six years of age and older weighing less than 40 kg with plaque psoriasis or psoriatic arthritis. For families navigating these chronic conditions, expanding access to treatments with proven efficacy supports improved disease management and extends established standards of care to younger patients."
Approximately 30% of people who develop psoriasis experience symptoms before age eighteen.1 Each year, approximately 20,000 children under ten years old are diagnosed with psoriasis in the U.S., and an estimated 14,000 children are impacted by psoriatic arthritis.1,2,3 Psoriasis and psoriatic arthritis symptoms in children can interfere with mobility and daily activities, with additional burden on caregivers.4,5
"For children impacted by immune-mediated diseases, childhood can become shaped by doctor appointments, uncertainty and the emotional weight of living with a chronic disease," said Leah M. Howard, J.D., president and chief executive officer, National Psoriasis Foundation. "Having an approved treatment for both skin and joint disease available for our younger patients gives families another much-needed option and offers a measure of hope as they navigate the challenges of these diseases."
Data Supporting SKYRIZI Pediatric Approvals
The pediatric psoriasis approval is supported by data from the Phase 3 OptIMMize psoriasis clinical trial program (NCT04435600; NCT04862286), including data from two lead-in pharmacokinetic cohorts, a randomized efficacy assessor-blinded active controlled cohort (12 to <18 years) and a single arm open label cohort (6 to <12 years). The pediatric psoriatic arthritis approval is supported by the OptIMMize psoriasis clinical trial program as well as population pharmacokinetic modeling and simulation based on well-controlled adult psoriatic arthritis studies.
The safety profile observed in pediatric plaque psoriasis patients treated with SKYRIZI was consistent with the established safety profile of SKYRIZI in adult patients with plaque psoriasis.
"At Week 16 in part 2 of the OptIMMize psoriasis clinical trial program, risankizumab demonstrated clinically meaningful improvements in sPGA and PASI responses, with responses maintained long-term with continued treatment," said Amy S. Paller, M.D., chair of dermatology and professor of pediatrics at Northwestern University Feinberg School of Medicine and study investigator in the OptIMMize program. "These clinical responses, combined with weight-based dosing for younger patients, may help physicians better support a broad range of children living with plaque psoriasis or psoriatic arthritis."
Patient Access and Support
AbbVie is committed to helping people access SKYRIZI and other medicines, including offering a patient support program and co-pay card that may reduce out-of-pocket costs to as little as $0 per month for eligible, commercially insured patients. For those with limited or no health insurance, AbbVie offers myAbbVie Assist, a patient assistance program that provides SKYRIZI at no charge to those who qualify. More information about this assistance program can be found at www.AbbVie.com/myAbbVieAssist.
About SKYRIZI® (risankizumab-rzaa)
SKYRIZI is an interleukin-23 (IL-23) inhibitor that blocks IL-23 by selectively binding to its p19 subunit. IL-23, a cytokine involved in inflammatory processes, is thought to be linked to a number of chronic immune-mediated diseases. SKYRIZI is approved by the U.S. Food and Drug Administration and the European Medicines Agency for the treatment of plaque psoriasis, psoriatic arthritis, Crohn's disease and ulcerative colitis.
SKYRIZI® (risankizumab-rzaa) U.S. Uses and Important Safety Information
SKYRIZI is a prescription medicine used to treat:
moderate to severe plaque psoriasis in adults and children 6 years of age and older who may benefit from taking injections or pills (systemic therapy) or treatment using ultraviolet or UV light (phototherapy). active psoriatic arthritis in adults and children 6 years of age and older. moderate to severe Crohn's disease in adults. moderate to severe ulcerative colitis in adults. IMPORTANT SAFETY INFORMATION
What is the most important information I should know about SKYRIZI® (risankizumab-rzaa)?
SKYRIZI is a prescription medicine that may cause serious side effects, including:
Serious allergic reactions:
Stop using SKYRIZI and get emergency medical help right away if you get any of the following symptoms of a serious allergic reaction: fainting, dizziness, feeling lightheaded
(low blood pressure) swelling of your face, eyelids, lips,
mouth, tongue, or throat trouble breathing or throat tightness chest tightness skin rash, hives itching Infections:
SKYRIZI may lower the ability of your immune system to fight infections and may increase your risk of infections. Your healthcare provider should check you for infections and tuberculosis (TB) before starting treatment with SKYRIZI and may treat you for TB before you begin treatment with SKYRIZI if you have a history of TB or have active TB. Your healthcare provider should watch you closely for signs and symptoms of TB during and after treatment with SKYRIZI.
Tell your healthcare provider right away if you have an infection or have symptoms of an infection, including: fever, sweats, or chills cough shortness of breath blood in your mucus
(phlegm) muscle aches warm, red, or painful skin
or sores on your body
different from your
psoriasis weight loss diarrhea or stomach pain burning when you urinate
or urinating more often
than normal Do not use SKYRIZI if you are allergic to risankizumab-rzaa or any of the ingredients in SKYRIZI. See the Medication Guide or Consumer Brief Summary for a complete list of ingredients.
Before using SKYRIZI, tell your healthcare provider about all of your medical conditions, including if you:
have any of the conditions or symptoms listed in the section "What is the most important information I should know about SKYRIZI?" have an infection that does not go away or that keeps coming back. have TB or have been in close contact with someone with TB. have recently received or are scheduled to receive an immunization (vaccine). Medications that interact with the immune system may increase your risk of getting an infection after receiving live vaccines. You should avoid receiving live vaccines right before, during, or right after treatment with SKYRIZI. Tell your healthcare provider that you are taking SKYRIZI before receiving a vaccine. are pregnant or plan to become pregnant. It is not known if SKYRIZI can harm your unborn baby. are breastfeeding or plan to breastfeed. It is not known if SKYRIZI passes into your breast milk. become pregnant while taking SKYRIZI. You are encouraged to enroll in the Pregnancy Registry, which is used to collect information about the health of you and your baby. Talk to your healthcare provider or call 1-877-302-2161 to enroll in this registry. Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
What are the possible side effects of SKYRIZI?
SKYRIZI may cause serious side effects. See "What is the most important information I should know about SKYRIZI?"
Liver problems may happen while being treated for Crohn's disease or ulcerative colitis: A person with Crohn's disease who received SKYRIZI through a vein in the arm developed changes in liver blood tests with a rash that led to hospitalization. Your healthcare provider will do blood tests to check your liver before, during, and at least up to 12 weeks of treatment, and may stop treatment with SKYRIZI if you develop liver problems. Tell your healthcare provider right away if you notice any of the following symptoms: unexplained rash, nausea, vomiting, stomach (abdominal) pain, tiredness (fatigue), loss of appetite, yellowing of the skin and eyes (jaundice), and dark urine.
The most common side effects of SKYRIZI in people treated for Crohn's disease and ulcerative colitis include: upper respiratory infections, headache, joint pain, stomach (abdominal) pain, injection site reactions, low red blood cells (anemia), fever, back pain, urinary tract infection, and rash.
The most common side effects of SKYRIZI in people treated for plaque psoriasis and psoriatic arthritis include: upper respiratory infections, headache, feeling tired, injection site reactions, and fungal skin infections.
These are not all the possible side effects of SKYRIZI. Call your doctor for medical advice about side effects.
Use SKYRIZI exactly as your healthcare provider tells you to use it.
SKYRIZI (risankizumab-rzaa) is available in a 150 mg/mL prefilled syringe and pen, a 55 mg/0.37 mL prefilled syringe, a 600 mg/10 mL vial for intravenous infusion, and a 180 mg/1.2 mL or 360 mg/2.4 mL single-dose prefilled cartridge with on-body injector.
This is the most important information to know about SKYRIZI. For more information, talk to your HCP.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
If you are having difficulty paying for your medicine, AbbVie may be able to help. Visit AbbVie.com/PatientAccessSupport to learn more.
Please click here for the Full Prescribing Information and Medication Guide.
About AbbVie in Immunology
AbbVie is relentless in our pursuit to redefine the standard of care for patients living with immune-mediated conditions, with the goal of helping them live a life free from the limitations of their disease. For more than 20 years, AbbVie has led and helped shape the field of immunology through groundbreaking science and trusted medicines. Building on deep expertise across gastroenterology, rheumatology and dermatology, and other areas of high unmet need, we continue to invest in a broad and differentiated pipeline – spanning innovative modalities, novel mechanisms of actions and next-generation approaches designed to conquer the complex biology underlying immune-mediated disease.
Today, more than 1 million patients worldwide are treated with AbbVie's immunology medicines, approved in more than 175 countries across 19 immune-mediated diseases that impact adult and pediatric populations. As we work to strengthen our legacy and drive the next wave of innovation, we remain focused on delivering meaningful progress for patients and expanding access to our medicines. For more information, please visit www.abbvie.com/immunology.
About AbbVie
AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, neuroscience and oncology – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on LinkedIn, Facebook, Instagram, X and YouTube.
Forward-Looking Statements
Some statements in this news release are, or may be considered, forward-looking statements for purposes of the Private Securities Litigation Reform Act of 1995. The words "believe," "expect," "anticipate," "project" and similar expressions and uses of future or conditional verbs, generally identify forward-looking statements. AbbVie cautions that these forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those expressed or implied in the forward-looking statements. Such risks and uncertainties include, but are not limited to, challenges to intellectual property, competition from other products, difficulties inherent in the research and development process, adverse litigation or government action, changes to laws and regulations applicable to our industry, the impact of global macroeconomic factors, such as economic downturns or uncertainty, international conflict, trade disputes and tariffs, and other uncertainties and risks associated with global business operations. Additional information about the economic, competitive, governmental, technological and other factors that may affect AbbVie's operations is set forth in Item 1A, "Risk Factors," of AbbVie's 2025 Annual Report on Form 10-K, which has been filed with the Securities and Exchange Commission, as updated by its Quarterly Reports on Form 10-Q and in other documents that AbbVie subsequently files with the Securities and Exchange Commission that update, supplement or supersede such information. AbbVie undertakes no obligation, and specifically declines, to release publicly any revisions to forward-looking statements as a result of subsequent events or developments, except as required by law.
References
Menter A et al. (2020). Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis in pediatric patients. Journal of the American Academy of Dermatology, 82(1), 161–201. https://doi.org/10.1016/j.jaad.2019.08.049 Brunello, Francesco et al. (2022). New Insights on Juvenile Psoriatic Arthritis. Frontiers in Pediatrics, 10, 884727. https://doi.org/10.3389/fped.2022.884727 Morgan, E. M., et al. (2019). Establishing an Updated Core Domain Set for Studies in Juvenile Idiopathic Arthritis: A Report from the OMERACT 2018 JIA Workshop. The Journal of Rheumatology, 46(8), 1006–1013. https://doi.org/10.3899/jrheum.181088 Salman, A., et al. (2018). Impact of psoriasis in the quality of life of children, adolescents and their families: a cross-sectional study. Anais Brasileiros de Dermatologia, 93(6), 819–823. https://doi.org/10.1590/abd1806-4841.20186981 National Psoriasis Foundation. For Parents: Emotional Impact. Available at: https://www.psoriasis.org/our-spot-emotional-impact/. Accessed June 2026. SOURCE AbbVie
, /PRNewswire/ -- RTX (NYSE: RTX) announced today that its board of directors declared a dividend of 73 cents per outstanding share of RTX common stock. The dividend will be payable on September 3, 2026 to shareowners of record at the close of business on August 14, 2026.
RTX has paid cash dividends on its common stock every year since 1936.
About RTX
With more than 180,000 global employees, we push the limits of technology and science to redefine how we connect and protect our world. With industry-leading capabilities, we advance aviation, engineer integrated defense systems for operational success, and develop next-generation technology solutions and manufacturing to help global customers address their most critical challenges. The company, with 2025 sales of more than $88 billion, is headquartered in Arlington, Virginia.
Cautionary Statement Regarding Forward-Looking Statements
This release includes statements related to dividends that constitute "forward-looking statements" under the securities laws. All forward-looking statements involve risks, uncertainties and assumptions that may cause actual results to differ materially from those expressed or implied in the forward-looking statements. Past dividends provide no assurance as to future dividends. The timing, payment and amount of future dividends, if any, could vary significantly from past dividends due to a number of risks and uncertainties. These factors include those described under the caption "Risk Factors" in our reports on Forms 10-K, 10-Q and 8-K filed with the SEC from time to time.
Rocket Lab spustila misi Victus Haze za 16 hodin a 42 minut od oznámení Space Force, čímž stanovila svůj rekord. Na orbitě aktivovala družici za 37 hodin a 36 minut, tedy hluboko pod 72hodinovým limitem.
On June 22, Rocket Lab (RKLB +4.67%) launched its Victus Haze mission just 16 hours and 42 minutes after receiving the U.S. Space Force's Notice to Launch. That beat its previous record by over ten hours and marked its fastest turnaround ever.
Once in orbit, it fully activated the spacecraft in 37 hours and 36 minutes, easily beating the Space Force's 72-hour deadline. SpaceX (SPCX +0.13%), which handled the other half of the Victus Haze mission, doesn't execute any short-notice "scramble" missions like Rocket Lab.
Image source: Getty Images.
The Victus Haze mission is an orbital game of "cat and mouse" to test how quickly the U.S. military responds to spaceborne threats. In May, SpaceX launched True Anomaly's Jackal satellite -- the "mouse" -- into orbit with its Falcon 9 rocket. Rocket Lab waited on standby until the Space Force ordered it to launch its own Pioneer satellite -- the "cat" -- with its Electron rocket. That mission's success suggests Rocket Lab's future is bright, but does it make its stock worth buying after its near-40% pullback over the past month?
Today's Change
(
4.67
%) $
3.77
Current Price
$
84.46
What does Rocket Lab do? Rocket Lab's Electron rocket carries much smaller payloads than SpaceX's Falcon rockets. It has launched the Electron 88 times to deploy over 260 small satellites, and its customers include NASA, the U.S. Space Force's Space Development Agency (SDA), the Swedish National Space Agency, Capella Space, Kinéis, and BlackSky Technology.
Rocket Lab successfully launched 21 Electron rockets in 2025 and aims to launch around 30 in 2026. It's also trying to launch its first Neutron rocket, which can carry much heavier payloads than the Electron, by the end of this year.
Over the next few years, Rocket Lab plans to expand into an "end-to-end" space company by producing more spacecraft, satellites, and subsystems, launching more "ride-share" services for third-party payloads, and improving its Photon satellite bus platform.
From 2025 to 2028, analysts expect Rocket Lab's revenue to grow at a 39.5% CAGR. They also expect it to turn profitable in the final year.
Why did Rocket Lab's stock decline? Rocket Lab, like many other space stocks, rallied in the month leading up to SpaceX's IPO. But after the IPO, many of those investors took profits and rotated to SpaceX instead. Some investors believe SpaceX's Starship, its largest rocket ever, could significantly reduce launch prices and hurt smaller rocket makers like Rocket Lab. Inflation and fears of interest rate hikes are also driving investors away from smaller, speculative stocks.
Even after its pullback, Rocket Lab trades at 51 times this year's sales, 36 times its 2027 sales, and 29 times its 2028 sales. It's a little cheaper than SpaceX, which trades at 55 times this year's sales, but it might be too hot to handle right now. Investors can nibble on Rocket Lab at these levels, but they shouldn't be surprised if it gets cut in half in the next market crash.
TNL Mediagene obdržela od Nasdaqu oznámení o delistingu kvůli ceně akcií pod 1 USD po dobu 30 po sobě jdoucích obchodních dnů a nesplnění kapitálového minima 2 500 000 USD. Firma požádá o slyšení, ticker TNMG zatím zůstává v obchodování.
Tokyo, Japan--(Newsfile Corp. - June 26, 2026) - TNL Mediagene (NASDAQ: TNMG) (the "Company"), a technology and digital media company providing AI-driven advertising, marketing technology, content commerce and data analytics solutions, and operating multi-language digital media brands across Asia, today announced that on June 22, 2026, the Company received a staff determination letter (the "Determination Letter") from the staff of the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that its securities are subject to delisting from The Nasdaq Capital Market.
The Determination Letter states that the closing bid price of the Company's ordinary shares has been below $1.00 per share for 30 consecutive business days, from May 7, 2026 through June 18, 2026, and the Company is therefore not in compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2). Because the Company effected a reverse stock split during the prior one-year period, pursuant to Listing Rule 5810(c)(3)(A)(iv) the Company is not eligible for any compliance period in connection with such non-compliance. The Company is also subject to a Discretionary Panel Monitor for a period of one year in accordance with Listing Rule 5815(d)(4)(A), as established by the Nasdaq Hearings Panel's letter dated January 20, 2026 and previously disclosed by the Company.
The Determination Letter further states that the Company's previously notified non-compliance with the $2,500,000 minimum stockholders' equity requirement under Nasdaq Listing Rule 5550(b)(1), as set forth in Staff's notification dated May 6, 2026 and previously disclosed by the Company on Form 6-K filed on May 12, 2026, serves as an additional and separate basis for delisting.
The Company intends to timely request a hearing before a Nasdaq Hearings Panel (the "Panel") to appeal the Determination Letter. The hearing request will automatically stay the suspension of the Company's securities and the filing of a Form 25-NSE pending the Panel's decision. At the hearing, the Company will present its plan to regain compliance with the applicable continued listing requirements. The Determination Letter has no immediate effect on the listing of the Company's ordinary shares on The Nasdaq Capital Market, which will continue to trade under the symbol "TNMG" pending the Panel's decision. There can be no assurance that the Panel will grant the Company's request for continued listing or that the Company will be able to regain compliance with the applicable Nasdaq listing requirements.
About TNL Mediagene
Headquartered in Tokyo, TNL Mediagene (NASDAQ: TNMG) is a technology and digital media company providing AI-driven advertising, marketing technology, content commerce and data analytics solutions, and operating multi-language digital media brands across Asia. Formed in May 2023 through the merger of Japan's Mediagene Inc. and Taiwan's The News Lens Co., Ltd., the Company combines advertising and marketing technology platforms with a portfolio of established digital media brands to deliver integrated solutions for the evolving digital landscape.
The Company's technology offerings include AI-driven advertising, marketing and digital studio services, content commerce, and advanced data analytics capabilities. These solutions are supported by the Company's well-established multi-language digital media brands in Japanese, Chinese, and English, spanning business, technology, lifestyle, and culture, which provide audience engagement and first-party data.
Known for its appeal to younger audiences, and high-quality content, TNL Mediagene has approximately 480 employees with offices in Japan and Taiwan.
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that are based on beliefs and assumptions and on information currently available to TNL Mediagene. Forward-looking statements generally relate to future events or TNL Mediagene's future financial or operating performance. In some cases, you can identify forward-looking statements by the following words: "may," "will," "could," "would," "should," "expect," "intend," "plan," "anticipate," "believe," "estimate," "predict," "project," "potential," "continue," "ongoing," "target," "aim," "seek" or the negative or plural of these words, or other similar expressions that are predictions or indicate future events or prospects, although not all forward-looking statements contain these words. Forward-looking statements in this communication include, but are not limited to, statements regarding statements about TNL Mediagene's future business plan and growth strategies, including any compliance plan, and statements by TNL Mediagene's management. Any statements that refer to expectations, projections or other characterizations of future events or circumstances, including strategies or plans, are also forward-looking statements. These statements involve risks, uncertainties and other factors that may cause actual results, levels of activity, performance or achievements to be materially different from those expressed or implied by these forward-looking statements. Forward-looking statements in this communication or elsewhere speak only as of the date made. New uncertainties and risks arise from time to time, and it is impossible for TNL Mediagene to predict these events or how they may affect TNL Mediagene. In addition, risks and uncertainties are described in TNL Mediagene's filings with the Securities and Exchange Commission, including the risks and uncertainties set forth under the heading "Risk Factors" in TNL Mediagene's FY2025 Annual Report on Form 20-F filed on April 30, 2026, as may be supplemented or amended by the TNL Mediagene's Reports of a Foreign Private Issuer on Form 6-K. These filings may identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. TNL Mediagene cannot assure you that the forward-looking statements in this communication will prove to be accurate. There may be additional risks that TNL Mediagene presently does not know or that TNL Mediagene currently does not believe are material that could also cause actual results to differ from those contained in the forward-looking statements. In light of the significant uncertainties in these forward-looking statements, you should not regard these statements as a representation or warranty by TNL Mediagene, its directors, officers or employees or any other person. Except as required by applicable law, TNL Mediagene does not have any duty to, and does not intend to, update or revise the forward-looking statements in this communication or elsewhere after the date of this communication. You should, therefore, not rely on these forward-looking statements as representing the views of TNL Mediagene as of any date subsequent to the date of this communication.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/302974
Source: TNL Mediagene
Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.
, /PRNewswire/ -- The AES Corporation (the "Company" or "AES") (NYSE: AES) today announced that its stockholders voted to approve the Company's previously announced acquisition by Global Infrastructure Partners ("GIP"), a part of BlackRock, and the EQT Infrastructure VI fund ("EQT"), along with co-underwriters California Public Employees' Retirement System ("CalPERS") and Qatar Investment Authority ("QIA") (collectively "the Consortium"), at the Company's Meeting of Stockholders held earlier today.
As previously announced, under the terms of the merger agreement the Consortium will acquire all outstanding common shares of AES for $15.00 per share in cash, representing a total equity value of approximately $10.7 billion and an enterprise value of approximately $33.4 billion, including the assumption of existing debt1.
"We are grateful for the strong support from our stockholders," said Holly Koeppel, Lead Independent Director of AES' Board of Directors. "Today's vote reinforces our conviction that this transaction meaningfully enhances value while positioning AES for its next phase of growth. With the deep sector expertise of the Consortium, AES will have greater flexibility to invest in the critical energy solutions our customers and communities depend on. We look forward to working with the Consortium to complete the transaction, advance our shared mission, and create long-term value for all stakeholders."
"Our team has built a differentiated platform spanning regulated utilities, clean energy solutions and critical energy infrastructure, creating a strong foundation for sustained growth," said Andrés Gluski, Chairman and Chief Executive Officer of AES. "With today's approval by stockholders, we are focused on executing the remaining steps towards completing the transaction and partnering with the Consortium to expand our capacity to deliver reliable, affordable and sustainable energy."
Based on the preliminary vote count from today's special meeting of stockholders, approximately 97.92% of AES stockholders votes were cast in favor of the proposed transaction, representing approximately 67.17% of all outstanding shares. The final voting results will be reported in a Form 8-K filed with the U.S. Securities and Exchange Commission.
The transaction is expected to close in late 2026 or early 2027, and remains subject to the receipt of applicable federal, state and foreign regulatory approvals and the satisfaction of other customary closing conditions.
About AES
The AES Corporation (NYSE: AES) is a Fortune 500 global energy company accelerating the future of energy. Together with our many stakeholders, we're improving lives by delivering the greener, smarter energy solutions the world needs. Our diverse workforce is committed to continuous innovation and operational excellence, while partnering with our customers on their strategic energy transitions and continuing to meet their energy needs today.
About Global Infrastructure Partners (GIP), a Part of BlackRock
Global Infrastructure Partners (GIP), a part of BlackRock, is a leading infrastructure investor that specializes in investing in, owning and operating some of the largest and most complex assets across the energy, transport, digital infrastructure and water and waste management sectors.
GIP's scaled platform has over $206 billion in assets under management. We believe that our focus on real infrastructure assets, combined with our deep proprietary origination network and comprehensive operational expertise, enables us to be responsible stewards of our clients' capital and create positive economic impact for communities.
About EQT
EQT is a purpose-driven global investment organization with EUR 269 billion in total assets under management (EUR 142 billion in fee-generating assets under management) as of 31 March 2026, within two business segments – Private Capital and Real Assets. EQT owns portfolio companies and assets in Europe, Asia Pacific and the Americas and supports them in achieving sustainable growth, operational excellence and market leadership.
About CalPERS
CalPERS is the largest defined benefit public pension fund in the U.S., with a net position of $597.7 billion in its Public Employees' Retirement Fund as of March 31, 2026. The portfolio invests in stocks, bonds, real estate, infrastructure, private equity, inflation-linked assets and other public and private investment vehicles, with a goal to generate total returns on a long-term basis while managing risk. Headquartered in Sacramento, California, CalPERS serves nearly 2.4 million members, providing retirement benefits to state, school, and public employees, along with health benefit services to 1.5 million members.
About QIA
QIA is the sovereign wealth fund of the State of Qatar. QIA was founded in 2005 to invest and manage the state reserve funds. QIA is among the largest and most active sovereign wealth funds globally. QIA invests across a wide range of asset classes and regions as well as in partnership with leading institutions around the world to build a global and diversified investment portfolio with a long-term perspective that can deliver sustainable returns and contribute to the prosperity of the State of Qatar.
Safe Harbor Disclosure
This news release contains forward-looking statements within the meaning of the Securities Act of 1933 and of the Securities Exchange Act of 1934. Such forward-looking statements include, but are not limited to, those related to future earnings, growth and financial and operating performance. Forward-looking statements are not intended to be a guarantee of future results but instead constitute AES' current expectations based on reasonable assumptions. Estimates and projections regarding, among other things, the expected date of closing of the transaction and the potential benefits thereof, its business and industry, management's beliefs and certain assumptions made by AES, all of which are subject to change. Forecasted financial information is based on certain material assumptions. These assumptions include, but are not limited to, our expectations regarding accurate projections of future interest rates, commodity price and foreign currency pricing, continued normal levels of operating performance and electricity volume at our distribution companies and operational performance at our generation businesses consistent with historical levels, as well as the execution of PPAs, conversion of our backlog and growth investments at normalized investment levels, and rates of return consistent with prior experience.
Actual results could differ materially from those projected in our forward-looking statements due to risks, uncertainties and other factors. Important factors that could affect actual results are discussed in AES' filings with the Securities and Exchange Commission (the "SEC"), including, but not limited to, the risks discussed under Item 1A: "Risk Factors" and Item 7: "Management's Discussion & Analysis" in AES' 2025 Annual Report on Form 10-K and in subsequent reports filed with the SEC. Readers are encouraged to read AES' filings to learn more about the risk factors associated with AES' business. AES undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except where required by law.
Any Stockholder who desires a copy of the Company's 2025 Annual Report on Form 10-K filed March 2, 2026 with the SEC may obtain a copy (excluding the exhibits thereto) without charge by addressing a request to the Office of the Corporate Secretary, The AES Corporation, 4300 Wilson Boulevard, Arlington, Virginia 22203. Exhibits also may be requested, but a charge equal to the reproduction cost thereof will be made. A copy of the Annual Report on Form 10-K may be obtained by visiting the Company's website at www.aes.com.
Contacts
AES Investor Contact:
Max Trask 571-217-3249, [email protected]
AES Media Contact:
Amy Ackerman 703-682-6399, [email protected]
GIP Contact:
Mustafa Riffat, 917-747-4156, [email protected]
Press Release
Investor Contact: Max Trask 571-217-3249, [email protected]
Media Contact: Amy Ackerman 703-682-6399, [email protected]
1Enterprise value based on proportional net debt of $22,724 million and a share count of 712 million, as of December 31, 2025. Consolidated net debt was $27,561 million as of December 31, 2025.
FDA vydal společnosti Lantheus kompletní zamítavý dopis k LNTH-2501 kvůli nevyřešeným výrobním podmínkám u třetí strany. Agentura neuvedla problémy s daty ani s bezpečností nebo účinností.
June 26, 2026 16:01 ET | Source: Lantheus Holdings, Inc.
BEDFORD, Mass., June 26, 2026 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus” or “Company”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, announced today that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding its New Drug Application (NDA) for LNTH-2501 (Gallium 68 edotreotide), a PET diagnostic imaging kit targeting somatostatin receptor-positive (SSTR+) neuroendocrine tumors (NETs).
The FDA stated that the agency cannot approve the NDA by the Prescription Drug User Fee Act (PDUFA) action date of June 29, 2026, due to unresolved third-party facility manufacturing-related conditions. The third-party facility is responsible for drug product manufacturing. Satisfactory resolution of the unresolved facility inspection-related conditions is required before the LNTH-2501 NDA may be approved.
The CRL did not identify any concerns regarding the data submitted by Lantheus in support of the application, nor did it identify any issues related to the safety or efficacy of LNTH-2501.
“We remain confident in LNTH-2501 and are committed to bringing this imaging agent to NETs patients and healthcare providers as soon as possible,” said Mary Anne Heino, Executive Chairperson and Chief Executive Officer, Lantheus. “The feedback received from the FDA relates solely to our third-party manufacturer, and not to the clinical performance of the product. We are working closely with our partner and the Agency to address these facility manufacturing-related conditions and advance the program.”
About LNTH-2501 (Ga 68 edotreotide)
LNTH-2501 (Kit for Preparation of Ga 68 edotreotide Injection), is an investigational radioactive diagnostic kit indicated for use with positron emission tomography (PET) for localization of somatostatin receptor positive neuroendocrine tumors (NETs) in adult and pediatric patients. LNTH-2501 is supplied as a 2-vial kit to radiopharmacies which allows for direct preparation of Ga 68 edotreotide injection with the eluate of Gallium from an on-site generator at the radiopharmacy. LNTH-2501 is not currently approved by the FDA and is not yet available for sale in the United States.
About Lantheus
Lantheus is the leading radiopharmaceutical-focused company, delivering life-changing science to enable clinicians to Find, Fight and Follow disease to deliver better patient outcomes. Headquartered in Massachusetts with offices in New Jersey, Canada, Germany, Sweden, Switzerland and the United Kingdom, Lantheus has been providing radiopharmaceutical solutions for 70 years. For more information, visit www.lantheus.com.
Safe Harbor for Forward-Looking and Cautionary Statements
This press release may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, that are subject to risks and uncertainties and are made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Readers are cautioned not to place undue reliance on the forward-looking statements contained herein, which speak only as of the date hereof. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law. Risks and uncertainties that could cause our actual results to materially differ from those described in the forward-looking statements include our ability to work with our third-party manufacturing partner to address the feedback outlined in the CRL in order to obtain a positive regulatory outcome from the FDA for LNTH-2501 and the risks and uncertainties discussed in our filings with the Securities and Exchange Commission (including those described in the Risk Factors section in our most recently filed Annual Report on Form 10-K and Quarterly Reports on Form 10-Q).
Contacts:
Lantheus
Mark Kinarney
Vice President, Investor Relations
978-671-8842 [email protected]
Ralph Lauren ve 4. čtvrtletí fiskálního roku 2026 zvýšil globální srovnatelné tržby v přímém prodeji spotřebitelům o 17 %. Digitální tržby vzrostly o 21 % v Severní Americe, 14 % v Evropě a 31 % v Asii.
Key Takeaways RL is executing its Next Great Chapter strategy to drive brand elevation and global expansion.Ralph Lauren is investing in personalization, digital capabilities and omnichannel experiences.RL reported 17% global DTC comps growth in Q4 fiscal 2026, with digital sales gains across regions. Ralph Lauren Corporation (RL - Free Report) continues to strengthen its long-term growth profile through disciplined execution of its Next Great Chapter strategy. The company is advancing its digital transformation through personalization, data-driven insights and seamless omnichannel experiences. RL leverages advanced data analytics to tailor product recommendations, optimize pricing and refine marketing strategies across regions.
Ralph Lauren’s Next Great Chapter initiative serves as the foundation of its growth strategy, emphasizing brand elevation, consumer centricity and operational agility. This strategy is designed to create a more balanced global footprint by expanding into high-growth markets, such as Asia, while strengthening its presence in core regions. The company continues to execute its “Next Great Chapter: Drive Plan,” which focuses on elevating and energizing the lifestyle brand, driving the core and expanding into higher-potential categories, and winning in key cities with its consumer ecosystem.
Digital sales now represent a growing share of total revenues, supported by continuous investments in personalization, enhanced mobile capabilities and integrated loyalty programs designed to connect with younger and more diverse consumers. Ralph Lauren is optimizing distribution, strengthening wholesale partnerships and enhancing its retail network to reinforce its premium positioning. The company has been experiencing significant growth in its digital channels across key regions. Continuous investments in personalization, mobile capabilities and loyalty integration have strengthened digital sales, enabling it to make deeper engagements with younger and more diverse consumer segments.
In fourth-quarter fiscal 2026, global direct-to-consumer comparable store sales (comps) increased 17%, with positive retail comps across regions and channels. Digital commerce improved 21% in North America, 14% in Europe and 31% in Asia. For fiscal 2027, the company expects constant currency revenues to increase approximately mid-single digits on a 52-week comparable basis, centered around 4-5%, and noted the 53rd week should add about one point to revenue growth and benefit operating margin.
RL’s Price Performance, Valuation and EstimatesRalph Lauren’s shares have gained 14.9% in the past six months against the industry’s 8.1% decline.
Image Source: Zacks Investment Research
From a valuation standpoint, RL is trading at a forward price-to-earnings ratio of 21.83X compared with the industry’s average of 14.92X.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for RL’s fiscal 2027 and fiscal 2028 earnings per share (EPS) indicates year-over-year growth of 10.5% each. The company’s EPS estimate for fiscal 2027 and fiscal 2028 has moved north in the past 30 days.
Image Source: Zacks Investment Research
Ralph Lauren currently carries a Zacks Rank #2 (Buy).
Other Key Picks in the Consumer Discretionary SpaceColumbia Sportswear Company (COLM - Free Report) , which engages in the sourcing, marketing and distribution of outdoor and active lifestyle apparel, footwear, accessories and equipment, currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
COLM delivered a trailing four-quarter earnings surprise of 44.1%, on average. The Zacks Consensus Estimate for Columbia Sportswear’s current financial-year sales indicates growth of 2.6% from the year-ago number.
Crocs, Inc. (CROX - Free Report) , which is a leading footwear company, currently carries a Zacks Rank of 2. CROX delivered a trailing four-quarter earnings surprise of 13.6%, on average.
The Zacks Consensus Estimate for Crocs’ current financial-year EPS indicates a rise of 9.3% from the year-ago number.
Gildan Activewear Inc. (GIL - Free Report) , which is a designer and marketer of premium quality branded basic activewear, currently has a Zacks Rank of 2.
GIL delivered a negative trailing four-quarter earnings surprise of 1.1%, on average. The Zacks Consensus Estimate for Gildan Activewear’s current financial-year sales indicates growth of 68.3% from the year-ago number.
CEO Sezzle Charlie Youakim tvrdí, že BNPL ukrajuje podíl hlavně regionálním bankám a družstevním záložnám, ne rivalům. Firma za 1. čtvrtletí vykázala tržby 135,54 mil. USD a čistý zisk 51,30 mil. USD.
Sezzle CEO and Executive Chairman Charlie Youakim appeared on CNBC’s Squawk Box on Friday, June 26, to argue that the buy-now-pay-later sector is pulling market share from legacy regional and community banks and credit unions that never built the digital-first payment rails that younger consumers now expect. “The losses are coming from these nonpublic companies… they just don’t have the technological solutions,” he said in the segment.
Sezzle (NASDAQ:SEZL) stock is up over 150% since the beginning of 2026 and up over 50% in the last month. The company’s market cap now sits near $5.36 billion.
The Bank Displacement Thesis Youakim’s central claim is that BNPL is taking wallet share from institutions that don’t have the technology stack to engage Gen Z and younger millennials. He pointed to Sezzle’s own app data as evidence the consumer remains healthy at the lower end, and said 70% of Sezzle’s customer base is 40 and under. He added that the cohort skews slightly older each year as customers stay with the product, a retention signal that supports the company’s lifetime-value pitch.
Youakim also framed BNPL as a structurally safer credit alternative to revolving credit cards because the product halts further purchases the moment a customer misses a payment. That circuit-breaker design, in his view, is one reason Sezzle’s loss curve has tightened even as GMV scales.
In Q1 2026, Sezzle posted $135.54 million in revenue, up 29.2% year over year, adjusted EPS of $1.43, and net income of $51.30 million, up 41.9%. GMV reached roughly $1.10 billion, active subscribers grew 48.4%, and average quarterly purchase frequency hit a company-record 7.1x.
Sezzle’s Pure-Play Short Duration Lending Differs from Affirm and Klarna Youakim drew a sharp line between Sezzle’s model and those of larger BNPL names. He described Sezzle as a “pure play” short-duration lender, with biweekly pay-in-five and 6- to 8-week loans that turn over multiple times a year. That structure, he argued, supports stronger return on equity and margins than longer-tenor installment books. He noted Affirm’s BNPL product is about 15% of its business, with the rest being long-duration installment lending, and grouped Klarna alongside Affirm on the long-duration side.
Sezzle’s reported financials support the margin angle. Operating margin runs at 61%, return on equity sits at 91.9%, and provision for credit losses improved to 1.2% of GMV from 1.6% a year earlier. Management has raised full-year guidance, now targeting revenue growth of 30-35%, adjusted net income of $180.0 million, and adjusted EPS of $5.10.
What To Watch Next Sezzle trades at a forward P/E of 19, with an average analyst price target of $134.33, which is well below the stock’s current price of $167.73. Investors interested in the business might consider tracking the company’s pending bank charter application, the rollout of Sezzle Mobile and Agentic Commerce in Canada, and credit performance as the loan book scales.
It’s important to keep in mind that CEO Youakim is a founder in the BNPL sector and probably carries some degree of bias. BNPL still carries real consumer credit exposure, is facing expanding regulatory scrutiny, and is facing active antitrust litigation against Shopify, all factors that could complicate the displacement story if the macro turns.
Healthpeak Properties za poslední tři měsíce vzrostla o 28 % díky silnému leasingu v laboratořích a ambulantní péči. Hotovost stoupla na 1,17 miliardy USD a firma přidala nový nezajištěný odloženě čerpaný termínový úvěr za 400 milionů USD.
Key Takeaways Healthpeak Properties is expanding labs, outpatient and life plan assets in high-barrier markets.DOC posted stronger lab and outpatient leasing, with higher occupancy and solid re-leasing spreads.Healthpeak Properties boosted liquidity with Janus IPO proceeds and added a $400M term loan. Shares of Healthpeak Properties (DOC - Free Report) have gained 28% in the past three months, outperforming the industry's upside of 12.4%.
This healthcare real estate company, carrying a Zacks Rank #3 (Hold), is strategically positioning itself toward lab, outpatient medical and life plan assets in high-barrier markets, driven by strong leasing momentum, rising occupancy and growth in its senior housing platform, Janus Living. Management is using dispositions and structured transactions to fund focused growth while enhancing liquidity and maintaining investment flexibility across cycles.
Image Source: Zacks Investment Research
Factors Behind DOC Stock Price Surge: Will the Trend Last?Healthpeak’s continued focus on the lab segment aligns well with long-term demand, since ongoing investment in drug discovery and development supports the need for high-quality lab real estate across its core clusters of San Diego, San Francisco, and Boston. During the first quarter of 2026, Healthpeak executed 141,000 square feet of lab leases, with 92% tied to new leasing, and had roughly 355,000 square feet under Letter of Intent. At the end of the first quarter of 2026, total lab occupancy was 77.7%, up from 77% at year-end 2025. Management expects year-end 2026 lab occupancy to be higher than the 2025 level.
The outpatient medical segment maintains solid fundamentals that generate consistent, recurring cash flow. In the first quarter of 2026, Healthpeak executed nearly 1.1 million square feet of outpatient leases, achieved 5.4% cash re-leasing spreads on renewals and ended the quarter at 91% total occupancy, with 79% tenant retention. Subsequent to quarter-end and through early May 2026, the company executed additional outpatient leasing activity and reported a larger pipeline under letter of intent (LOI), which should help sustain occupancy and rent growth over time.
Healthpeak’s exposure to life plan communities remains tied to demand for senior housing services, and the Janus Living structure adds a clearer vehicle for growth. In the first quarter of 2026, senior housing same-store cash (adjusted) net operating income (NOI) grew 13.8% year over year, reflecting stronger operating performance in the life plan portfolio. Janus Living reported year-over-year revenue growth of 35% and adjusted EBITDA expansion of 42% for the quarter.
Healthpeak is repositioning its portfolio toward labs, outpatient medical facilities, and life-plan properties in high–barrier-to-entry markets, funding this growth through asset sales and structured financing transactions. In the first quarter of 2026, the company generated $267 million of proceeds from recapitalizations, dispositions and loan repayments. These actions support a longer-term approach to driving per-share earnings growth while keeping investment activity flexible across cycles.
Healthpeak moved to strengthen near-term liquidity. At the end of the first quarter of 2026, its net debt-to-EBITDA was 5.4X. Cash and cash equivalents climbed to $1.17 billion from $467.5 million in the prior quarter, driven largely by proceeds from the Janus Living IPO. As of May 4, 2026, the company’s long-term credit ratings were Baa1 (Moody’s) and BBB+ (S&P Global). It also increased financial flexibility with a new $400 million unsecured delayed-draw term loan.
Key Risks for DOCCompetition from other industry players in the healthcare services sector is a key concern for Healthpeak. Risks associated with rising construction costs and substantial debt burden add to its woes.
Stocks to ConsiderSome better-ranked stocks from the broader REIT sector are Cousins Properties (CUZ - Free Report) and Prologis (PLD - Free Report) , each carrying a Zacks Rank #2 (Buy) at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
The Zacks Consensus Estimate for CUZ’s 2026 FFO per share is pegged at $2.94, which indicates year-over-year growth of 3.52%.
The Zacks Consensus Estimate for PLD’s full-year FFO per share is pinned at $6.18, which calls for an increase of 6.37% from the year-ago period’s level.
Note: Anything related to earnings presented in this write-up represents FFO, a widely used metric to gauge the performance of REITs.
Amazon Web Services zvýšil ceny rezervací EC2 Capacity Blocks for ML zhruba o 20 % od července. Jde o další signál, že nedostatek paměťových čipů zdražuje AI cloud.
By You're currently following this author! Want to unfollow? Unsubscribe via the link in your email.
An AWS data center Noah Berger/Getty Images via Amazon Web Services Amazon raised prices for several key AI cloud offerings, the latest sign that memory chip shortages are driving up the cost of some technology.
Amazon Web Services recently announced price increases for EC2 Capacity Blocks for ML. This is a cloud service that lets companies reserve GPUs in advance.
The changes mean hourly rates for renting several types of cloud servers will jump by roughly 20% starting in July. AWS had already raised prices for the same service by about 15% in January.
"Amazon EC2 Capacity Blocks for ML reservation prices are updated periodically based on supply and demand," the company said in its announcement. Amazon didn't immediately respond to a request for comment on Friday.
Similar price increases are happening in other parts of the tech industry, as tech giants pass memory price pressure on to customers. Apple raised prices this week, blaming soaring memory chip costs. Xbox did the same, and Elon Musk complained about unprecedented memory price increases.
The AWS move is more consequential than your next MacBook or gaming console costing a couple of hundred dollars more. As the world's largest cloud provider, AWS underpins many software services, and millions of developers rely on the cloud service to offer apps and other tech products. Price increases of 15% and now 20% will likely ripple through these sectors in coming quarters.
The price hikes reflect a broader shift in tech: AI is increasingly constrained by physical limitations, rather than software availability. Tight memory chip supply and strong GPU demand are raising costs for cloud providers.
One of the biggest physical constraints right now is high-bandwidth memory, a critical component packaged alongside advanced AI chips. AI cloud services run on these chips and servers, so shortages and price increases like this have a big impact on data center expansion plans and, ultimately, the supply of AI.
"As there is a limit to how much memory can be produced, then there is a limit to how many GPUs can be produced, which means that there's a limit to how many data centers can be built," Peter Berezin, chief economist at BCA Research, wrote on X on Friday.
Berezin added that cloud providers can pass on higher infrastructure costs because customers have few alternatives when GPU capacity is scarce, giving hyperscalers AWS, Microsoft, Google, and Oracle greater pricing power.
"While the memory shortage raises their costs, it also keeps the demand for compute above the available supply, which gives them greater pricing power over access to cloud computing," Berezin wrote on X.
The same shortages pushing up AI cloud prices have propelled memory-chip makers such as Micron and SK Hynix to records, reflecting investor expectations that AI-driven demand will keep the market tight, and prices high, for years.
Have a tip? Contact this reporter via email at [email protected] or Signal, Telegram, or WhatsApp at 650-942-3061. Use a personal email address, a nonwork WiFi network, and a nonwork device; here's our guide to sharing information securely.
Read next
Eugene Kim You're currently following this author! Want to unfollow? Unsubscribe via the link in your email.
Eugene is Business Insider’s Chief Tech Correspondent, where he leads coverage of Amazon. His reporting spans the company’s retail operations, AWS, Alexa, and its secretive internal work culture.Previously, he worked at CNBC, Fortune Magazine Korea, and Japan's Yomiuri Shimbun. He holds degrees from NYU and Columbia University’s Graduate School of Journalism.In 2022, Eugene broke a story uncovering Amazon’s practice of deceptively enrolling customers in Prime and deliberately making cancellation difficult. A year later, the Federal Trade Commission sued the company, citing his reporting. That case culminated in a record $2.5 billion settlement in 2025.His reporting has earned multiple honors, including the SF Press Club’s Bay Area Journalism Award and SPJ NorCal’s Excellence in Journalism Award.Eugene lives in the Bay Area. Contact him via email at [email protected], or Signal, Telegram, or WhatsApp at 650-942-3061. Use a personal email address, a nonwork WiFi network, and a nonwork device; here's our guide to sharing information securely. ExpertiseAmazon, Jeff Bezos, Andy Jassy, e-commerce, and cloud computing.Popular ArticlesAmazon:Internal Amazon emails give an exclusive look at how CEO Andy Jassy has started to run the company, with obsessive attention to the retail business and what some employees feel is micromanagingAndy Jassy will be the next CEO of Amazon. Insiders dish on what it's like to work for Jeff Bezos' successor, who built AWS into a $40 billion business.Internal documents show Amazon has for years knowingly tricked people into signing up for Prime subscriptions. 'We have been deliberately confusing,' former employee says.Inside Amazon's flailing brick-and-mortar ambitions: missed projections, pressure to cut costs, and a war with Whole FoodsInside Amazon's complex employee-review system, where workers feel left in the dark and managers expect to give 5% of reports bad reviewsAfter 28 years, 'Day 2' finally arrives at AmazonAWS, Alexa, healthcare:Inside Amazon's struggle to break into the lucrative market for SaaS business applications, including an internal pitch to buy $38 billion HubSpotInside Amazon's struggle to crack Nvidia's AI-chip dominanceAmazon's AI data center dream runs into the reality of 'zombie' facilities, higher costs, and labor shortagesAmazon is gutting its voice assistant, Alexa. Employees describe a division in crisis and huge losses on 'a wasted opportunity.'Amazon is working on a new 'Remarkable Alexa,' but internal politics and technical issues plague the projectAmazon projected huge losses from its healthcare business in 2024, but strong sales growth, internal document reveals
AWS Cloud Computing Amazon More Amazon Web Services Apple Inflation Artificial Intelligence
Bank of America snížila odhad zisku PepsiCo na fiskální rok 2026 na 8,61 USD z 8,65 USD a výhled tržeb kvůli slabšímu severoamerickému snackovému byznysu PFNA. Odhad zisku za 2. čtvrtletí snížila na 2,18 USD z 2,19 USD, výhled organického růstu tržeb za čtvrtletí na 2,9 % z 3,1 % a celoroční výhled na 3,0 % z 3,4 %. Mezinárodní trhy zůstávají silnější, ale obnova má trvat déle.
PepsiCo Inc (NASDAQ:PEP, XETRA:PEP) earnings outlook was trimmed by Bank of America analysts ahead of the company’s second quarter results, with softer-than-expected performance in its North American snacks business offsetting steadier international trends.
The analysts lowered their fiscal 2026 earnings per share (EPS) estimate to $8.61 from $8.65 and slightly reduced their second quarter forecast to $2.18 from $2.19. The revision reflects weaker performance at PepsiCo Foods North America (PFNA) and expectations that its recovery will take longer to materialize in the second half of the year.
For the quarter, Bank of America now expects consolidated organic sales growth of 2.9%, down from a prior estimate of 3.1%. The full-year organic sales growth outlook was also cut to 3.0% from 3.4%.
Despite the downward revisions, the analysts noted continued strength in international markets, which are now expected to deliver 5.4% organic sales growth in the second quarter, up from a prior forecast of 4.9%. They suggested PepsiCo could still reiterate its full-year guidance when it reports results on July 9, though the underlying mix of performance may be less favorable.
The primary pressure point remains PFNA, where scanner data indicated a sequential deterioration in trends during the quarter. NielsenIQ data showed retail sales growth slowing to a 1.0% decline in the second quarter from 0.6% growth in the first. Bank of America attributed the weakness to macroeconomic pressures, inflation, and unfavorable weather conditions around Memorial Day.
As a result, the analysts now expect flat organic sales growth for PFNA in the second quarter, compared with a previous estimate of 1.5%, and have reduced their full-year forecast to 0.2% from 1.4%. They also pointed to softer sequential performance across major brands including Lay’s, Doritos, Tostitos, Cheetos, and Ruffles.
In contrast, PepsiCo’s beverages division showed modest improvement. Retail sales in North America rose 0.3% year over year in the second quarter, while volumes fell 3.5%, an improvement from the prior quarter. However, analysts noted ongoing challenges for core brands, with Pepsi continuing to lose market share and Mountain Dew underperforming its category.
Bank of America also lowered its price objective on PepsiCo to $164 from $173, based on 18 times estimated 2027 earnings, down from a prior multiple of 19 times. Shares traded hands at about $142 on Friday afternoon.
The firm maintained its ‘Neutral’ rating on the stock.
Bluewater dokončila akvizici Suilend včetně STEAMM a SpringSui, čímž sjednotila klíčovou DeFi infrastrukturu na Sui. SEND token do dohody zahrnut nebyl.
Bluewater has completed the acquisition of Suilend, picking up the lending protocol along with its two companion products, STEAMM and SpringSui. The deal brings together some of the most active DeFi infrastructure on the Sui blockchain under a single owner, while leaving day-to-day operations largely unchanged for existing users.
What the Deal Covers Suilend is the largest lending and DeFi platform on the Sui blockchain. The protocol offers lending and borrowing, liquid staking through SpringSui, and automated market-making through STEAMM, a capital-efficient AMM that channels idle liquidity into lending pools for additional yield.
Bluewater said the acquisition deepens its long-term commitment to lending, liquid staking, and onchain capital markets on Sui. Suilend and Bluefin will maintain separate brands and legal structures but plan deeper integration across trading, lending, collateral, and liquidity. Zabi, co-founder of Bluefin, will serve as CEO. Zabi has assured that his commitment to Bluefin remains unchanged and that the acquisition will not impact Bluefin's development objectives.
The acquisition does not include the SEND token, which will be distributed to holders through a separate liquidation process.
Business as Usual for Users Suilend will continue operating independently, retaining its brand, product direction, and infrastructure. The team will adopt a gradual, security-first approach during the transition. Users need take no action, as existing positions and protocol functionalities will remain fully operational.
The acquisition was partly financed through Bluefin's relationship with SUI Group Holdings (NASDAQ: SUIG). Under an amended and restated digital currency loan agreement, SUI Group lent an additional 4 million $SUI to Bluefin, bringing total SUI on loan to 6 million. This supports Bluewater's acquisition of Suilend-related assets from Concurrent C, Inc. SUI Group also increased its revenue share to 11%, payable in $SUI, up from 5% under the original September 2025 agreement.
Sources:
Business Wire: SUI Group Expands Strategic Partnership with Bluefin
Crypto Briefing: SUI Group Lends Additional 4M SUI to Bluefin
KuCoin News: Bluewater Acquires Suilend and Its Products
FedEx Freight oznámil čtvrtletní upravený provozní zisk 363 milionů USD, o 27 milionů USD více, než se čekalo, díky silnějším cenám a vyšším výnosům na zásilku. Tržby vzrostly o 5 % na 2,41 miliardy USD.
Analyst Ken Hoexter said the less-than-truckload carrier delivered fiscal fourth-quarter adjusted operating income above expectations, driven by stronger pricing, higher revenue per shipment and increased weight per shipment.
Revenue rose 5% year over year to $2.41 billion, while adjusted operating income reached $363 million, topping the firm’s forecast by $27 million.
Transition Outlook ImprovesFedEx Freight also introduced financial targets for its June-to-December 2026 transition period, projecting revenue growth of 4% to 6%, adjusted operating income of $605 million to $645 million, adjusted operating margins of 11.5% to 12.0%, and adjusted earnings of $2.40 to $2.60 per share. Hoexter raised his estimates to reflect the stronger outlook.
The analyst expects earnings growth during the transition period to be driven primarily by pricing, with higher yields expected to add roughly 200 basis points to margins.
Efficiency initiatives are also expected to support profitability, although variable compensation costs, transition service agreement expenses and softer shipment volumes are likely to partially offset those gains.
Margin Expansion Remains Key ThesisBofA increased its 2027 earnings estimate by about 2% to $5.41 per share and said FedEx Freight’s focus on profitable revenue growth and long-term margin improvement supports a higher valuation.
Hoexter said management believes the ongoing unwinding of bundled customer contracts poses limited pricing risk because only about 10% of revenue is tied to those agreements and discounts have averaged just 1% to 3%.
Management also identified retail, healthcare, grocery, data centers and small- to medium-sized businesses as key growth markets.
FDXF Stock Price Activity: FedEx Freight shares were down 4.79% at $150.93 at the time of publication on Thursday, according to Benzinga Pro data.
Photo via Shutterstock
Market News and Data brought to you by Benzinga APIs
Parker-Hannifin oznámil, že organické tržby divize Aerospace Systems ve 3. čtvrtletí fiskálního roku 2026 vzrostly meziročně o 14,2 %. Firma zároveň čeká další růst díky poptávce v letectví a silným výdajům na obranu.
Key Takeaways Parker-Hannifin's Aerospace Systems organic revenues rose 14.2% in fiscal Q3 2026.PH expects aerospace sales growth from air transport demand and strong defense spending.Parker-Hannifin agreed to acquire CIRCOR's aerospace business for $2.55 billion. Parker-Hannifin Corporation (PH - Free Report) is witnessing persistent strength in its Aerospace Systems segment. The segment is benefiting from strength across its commercial and defense end markets across both Original Equipment Manufacturer (OEM) and aftermarket channels. Segmental organic revenues jumped approximately 14.2% year over year in the third quarter of fiscal 2026 (ended March 2026).
The Aerospace Systems segment is expected to capitalize on the strong demand for its products and aftermarket support services in the general aviation market, driven by growth in air transport activities. Strength in its defense end market, owing to robust U.S. and international defense spending volumes, is also likely to be beneficial. Parker-Hannifin expects the Aerospace Systems segment’s organic sales to increase 12% from the year-ago level in fiscal 2026 (ending June 2026).
In May 2026, the company also entered into a deal with CIRCOR International to acquire the latter’s Commercial and Defense Aerospace business for $2.55 billion. The transaction, anticipated to close in the second half of this year, will add complementary technologies and capabilities, thereby further strengthening its position across aerospace and defense markets.
Driven by strength in its businesses, Parker-Hannifin has issued bullish fiscal 2026 guidance. The company currently expects total sales to increase 7% year over year, while organic sales are projected to grow 5.5%.
Segment Snapshot of PH’s PeersAmong its major peers, Howmet Aerospace Inc.’s (HWM - Free Report) defense aerospace market is playing an important role in driving its overall growth. In the first quarter of 2026, Howmet’s revenues from the defense aerospace market jumped 10% year over year, which accounted for 16% of its total sales. The surge in revenues was fueled by robust demand for Howmet’s engine spares and an increase in orders for new builds and legacy fighter jet parts.
RBC Bearings Incorporated (RBC - Free Report) is gaining from the strong performance of the Aerospace/Defense segment. Strength in the commercial aerospace market, driven by strong growth in orders from the OEM and the aftermarket verticals, is driving the Aerospace/Defense segment. The segment’s revenues were up 41.2% year over year in fourth-quarter fiscal 2026 (ended March 2026).
PH's Price Performance, Valuation and EstimatesShares of Parker-Hannifin have gained 11.1% in the past six months compared with the industry’s growth of 6.3%.
Image Source: Zacks Investment Research
From a valuation standpoint, PH is trading at a forward price-to-earnings ratio of 29.13X, above the industry’s average of 22.76X. Parker-Hannifin carries a Value Score of F.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for PH’s fiscal 2026 earnings has increased 0.7% over the past 60 days.
Image Source: Zacks Investment Research
Parker-Hannifin currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
MercadoLibre ve 1. čtvrtletí zvýšila tržby o 49 %, ale provozní zisk klesl z 763 mil. USD na 611 mil. USD kvůli silnější konkurenci v Brazílii. Akcie jsou za poslední rok asi o 36 % níže.
MercadoLibre (MELI +3.06%) might not be a household name in the U.S., but Foolish investors know the Latin American e-commerce company as a standout on the stock market.
Since its 2007 IPO, MercadoLibre is up more than 5,000%, and it's built an Amazon-like network of businesses as it expands across Latin America, including in logistics, fintech, credit, and asset management. It's also added its Prime-like MELI+ membership program to help lock customers into its ecosystem.
While MercadoLibre has continued to put up strong growth numbers, the stock has struggled over the last year, falling 36% in a steady decline.
MELI data by YCharts
That sell-off isn't unwarranted, as there are several reasons why investors have sold off MercadoLibre stock. Let's take a look at those challenges before discussing whether MercadoLibre is a buy.
Image source: MercadoLibre.
What's ailing MercadoLibre? The biggest reason for MercadoLibre's slide is that its profits are falling. In the first quarter, despite a 49% jump in revenue, operating income slipped from $763 million to $611 million.
The decline in profits has come primarily as the company has faced increased competition in Brazil from Sea Limited's Shopee, PDD Holdings' Temu, Amazon, and others. Brazil is MercadoLibre's biggest market, representing about half of its revenue.
To push back against competition, MercadoLibre lowered its free shipping threshold in Brazil, or the minimum order value to get free shipping, which helped accelerate GMV growth to a currency-neutral 38%.
Management first introduced free shipping in 2016, which had a similar headwind on profit margins, but paid off over the longer run, and it expects the lower free shipping threshold to do the same.
The company is also investing in cross-border trade for merchants in China and the U.S., giving them the option to work with the regional leader rather than Amazon or Temu. It's given sellers easier access to free shipping and other incentives, and it opened its first fulfillment center in China to improve relationships with merchants there.
MercadoLibre's margins are also compressing due to the growth of lower-margin businesses, including its first-party e-commerce business and its credit business, which saw a modest rise in delinquency rates in the first quarter.
The credit business introduces a new risk for MercadoLibre, but management sees it as a key driver for the company's two principal businesses, e-commerce and fintech. Its credit portfolio increased 87% to $14.6 billion in the first quarter, and it issued 2.7 million MercadoPago credit cards.
Today's Change
(
3.06
%) $
49.58
Current Price
$
1668.83
It's understandable why falling profits would send MercadoLibre stock lower. After all, this is a stock that has historically traded at a premium valuation priced for growth.
However, the overall picture of the company is that the margin compression is primarily the result of its own decision-making to prioritize long-term growth over short-term profits in a shifting competitive landscape. That's a smart move, and it's similar to the strategy that worked so well for Amazon.
While competition may be impacting MercadoLibre's performance, market share wars don't last forever, as the experience of industries like ridesharing and food delivery has shown. Additionally, MercadoLibre actually gained market share in the first quarter, and its structural advantages, like its MercadoEnvios logistics network, should ensure that it maintains its leadership in Brazil and elsewhere. Management also believes that there's a long runway for growth in Latin American e-commerce as the average Latin American makes just seven online purchases a year, compared to 41 for the average American, so there can be more than one winner here.
The margin pullback is likely temporary, and these investments should pay off. In the meantime, MercadoLibre continues to deliver strong revenue growth, up 49% in the first quarter, a sign of a healthy business despite the bottom-line woes.
With the e-commerce stock down nearly 40% from its peak, MercadoLibre is worth buying here. The long-term growth outlook still looks strong.
Key Takeaways BF.B is expanding its premium portfolio and innovation to strengthen pricing power and long-term growth.Brown-Forman is benefiting from strong emerging-market demand, led by Jack Daniel's brands and New Mix.BF.B expects emerging markets and Travel Retail to remain key growth drivers in fiscal 2027. Brown-Forman Corporation (BF.B - Free Report) leverages its brand strength and premiumization strategy as important drivers for long-term growth. By focusing on well-established, globally recognized labels and expanding premium expressions, the company is reinforcing pricing power, supporting margins and prioritizing value-led growth.
The company is focused on leveraging its iconic brands, expanding its premium portfolio, driving innovation and accelerating global growth. Brown-Forman’s premiumization strategy emphasizes strengthening its portfolio through high-quality, premium brands to capitalize on consumers’ growing preference for authentic spirits. The company is also expanding its premium-plus and super-premium offerings, particularly in emerging markets where consumer demand has remained relatively resilient.
Brown-Forman is strengthening its premium positioning through route-to-consumer initiatives as well. A key priority is portfolio premiumization and innovation, with continued investment in premium-plus brands and new product launches like flavored whiskey variants, which are generating strong consumer engagement and helping drive incremental growth. The company is also advancing its Ready-to-Drink portfolio, expanding offerings such as New Mix and testing launches in new markets.
Brown-Forman has been seeing momentum across its Emerging markets for a while now. In fiscal 2026, net sales in Emerging markets increased 14% on a reported basis and 12% on an organic basis. The increase was driven by growth across the Jack Daniel’s family of brands, led by Türkiye, the United Arab Emirates and Brazil. It was also supported by robust double-digit growth of New Mix in Mexico, an estimated net increase in distributor inventories and favorable foreign exchange.
Brown-Forman’s emerging markets continue to serve as an important growth driver, supported by resilient demand trends. The company is expanding the distribution of super-premium whiskey brands in markets such as Brazil, where it sees long-term opportunity. Overall, emerging markets remain a key pillar of growth, backed by demand resilience, distribution gains, premiumization and targeted investment. In fiscal 2027, management expects continued growth across the emerging international markets and the Travel Retail channel.
BF.B’s Price Performance, Valuation and EstimatesBrown-Forman shares have gained 5.1% in the past six months compared with the industry’s 17.4% growth.
Image Source: Zacks Investment Research
From a valuation standpoint, BF.B trades at a forward price-to-earnings ratio of 16.14X compared with the industry’s average of 15.71X.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for BF.B’s fiscal 2027 and fiscal 2028 earnings per share (EPS) indicates year-over-year growth of 11.8% and 1.4%, respectively. The company’s EPS estimate for fiscal 2027 and fiscal 2028 has increased in the past 30 days.
Image Source: Zacks Investment Research
Brown-Forman currently carries a Zacks Rank #3 (Hold).
Stocks to Consider in the Consumer Staples Space The Chefs' Warehouse, Inc. (CHEF - Free Report) , which is a distributor of specialty food products in the United States, currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for Chefs' Warehouse's current financial-year sales indicates growth of 8.3% from the prior-year level. CHEF delivered a trailing four-quarter earnings surprise of 28.9%, on average.
Nomad Foods Limited (NOMD - Free Report) , which manufactures and distributes frozen foods, currently carries a Zacks Rank #2 (Buy).
The consensus estimate for Nomad Foods’ current financial-year sales is expected to rise 0.5% from the year-ago reported figure. NOMD delivered a trailing four-quarter earnings surprise of 8.6%, on average.
Medifast, Inc. (MED - Free Report) , which is a leading manufacturer and distributor of clinically-proven healthy living products and programs, currently carries a Zacks Rank of 2. MED delivered an average earnings surprise of 65.5% in the last reported quarter.
The Zacks Consensus Estimate for Medifast’s current financial-year sales indicates a decline of 26% from the year-ago number.
Na ZoomInfo Technologies byla podána hromadná žaloba kvůli údajným klamavým tvrzením o zpomalující poptávce a slabších vyhlídkách. Po snížení celoročního výhledu tržeb o zhruba 62 milionů USD akcie spadly asi o 33 %.
NEW YORK, June 26, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against ZoomInfo Technologies Inc. (NASDAQ: GTM) and certain of its officers.
This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired ZoomInfo securities between November 3, 2025 and May 11, 2026, both dates inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: bgandg.com/GTM.
ZoomInfo Case Details
The Complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements and/or failed to disclose:
The true state of ZoomInfo's slowing seat-based demand, weakening upsell opportunities, and deteriorating fundamentals across its downmarket and upmarket segments.
That Defendants' optimistic growth narrative, including representations that full-year 2026 revenue guidance of $1.247–$1.267 billion was achievable and that Copilot penetration was on or ahead of schedule. That customers were migrating toward consumption-based models and developing internal AI-driven go-to-market solutions, trends Defendants minimized despite their material adverse impact on ZoomInfo's business.
On May 11, 2026, ZoomInfo reported its first quarter 2026 results and slashed its full-year revenue guidance by approximately $62 million
Following this news, the price of ZoomInfo's common stock declined dramatically, from a closing market price of $6.04 per share on May 11, 2026, ZoomInfo's stock price fell to $4.06 per share on May 12, 2026, a decline of about 33%.
What's Next for ZoomInfo Investors?
A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm’s site: bgandg.com/GTM. or you may contact Peretz Bronstein, Esq. or his Client Relations Manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC at 917-590-0911. If you suffered a loss in ZoomInfo you have until August 24, 2026, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as lead plaintiff.
No Cost to ZoomInfo Investors
We, Bronstein, Gewirtz & Grossman LLC, represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys’ fees, usually a percentage of the total recovery, only if we are successful.
Why Bronstein, Gewirtz & Grossman, LLC for ZoomInfo Securities Class Action?
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide. More at www.bgandg.com
"Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace," said Peretz Bronstein, Founding Partner of Bronstein, Gewirtz & Grossman, LLC.
Follow us for updates on LinkedIn, X, Facebook, or Instagram.
Contact Info
Peretz Bronstein, Esq. or Nathan Miller
Bronstein, Gewirtz & Grossman, LLC
917-590-0911 | [email protected]
Attorney advertising.
Prior results do not guarantee similar outcomes.
Key Takeaways Elevance Health's Carelon contributes 36.3% of operating revenues, expanding beyond health insurance.ELV said CareBridge cut readmissions 20% and saved over 10% in post-acute care costs.Carelon's Q1 2026 operating gain fell 3.8%, but investments support long-term growth prospects. Carelon is emerging as a key pillar of Elevance Health, Inc.'s (ELV - Free Report) long-term growth strategy as the company expands beyond traditional health insurance. Through its integrated care delivery, pharmacy and care management businesses, Carelon is helping improve clinical outcomes while creating new revenue opportunities. The segment now contributes around 36.3% of Elevance Health's total operating revenues, underscoring its growing role in the company's diversified business model.
The business is also becoming a meaningful driver of operational efficiency. Carelon combines AI, predictive analytics and coordinated care programs to identify high-risk patients earlier and intervene before medical conditions worsen. Its integrated CareBridge and care-at-home platform has reduced hospital readmissions by 20% while generating over 10% savings in post-acute care costs. These capabilities also support higher medication adherence, fewer emergency room visits and improved care coordination, reinforcing Carelon's competitive position.
However, Carelon's first-quarter 2026 operating gain declined 3.8% year over year due to lower affiliated health plan membership and continued investments in expanding risk-based programs. Even so, these investments are laying the foundation for future growth. Specialty pharmacy, CareBridge and integrated medical-pharmacy solutions continue to gain traction, supporting Carelon's long-term growth prospects as employers seek more cost-effective healthcare solutions.
Carelon's growing role complements ELV's broader financial momentum. Operating revenues rose 1.5% year over year in the first quarter of 2026, and the company raised its 2026 adjusted EPS guidance to at least $26.75. As Carelon scales its clinical and pharmacy capabilities, it is well positioned to become a key contributor to Elevance Health's earnings growth and competitive advantage.
How Are Competitors Faring?
Some of ELV’s major competitors in the value-based care space are UnitedHealth Group Incorporated (UNH - Free Report) and Humana Inc. (HUM - Free Report) .
UnitedHealth, through its Optum segment, is scaling AI-driven care management, pharmacy and provider solutions to improve care coordination and operational efficiency. Its integrated care model supports value-based reimbursement while diversifying revenues beyond its insurance business. UnitedHealth’s total revenues rose 2% year over year in the first quarter of 2026.
Humana is strengthening its integrated care strategy through CenterWell, which combines primary care, home health and pharmacy services. The company continues expanding value-based care and home-based services, aiming to improve patient outcomes while controlling medical costs. Humana’s total revenues rose 23.5% year over year in the first quarter of 2026.
Elevance Health’s Price Performance, Valuation & EstimatesShares of ELV have risen 12.1% in the year-to-date period against the industry’s fall of 2.9%.
Image Source: Zacks Investment Research
From a valuation standpoint, Elevance Health trades at a forward price-to-earnings ratio of 13.85, below the industry average of 15.70. ELV carries a Value Score of A.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for Elevance Health’s 2026 earnings is pegged at $26.92 per share, implying an 11.1% drop from the year-ago period.
Image Source: Zacks Investment Research
ELV stock currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Rocket Lab úspěšně vynesl další satelit pro Synspective, čímž dokončil desátý dedikovaný start této japonské firmy se 100% úspěšností mise. Pro Synspective jde o 12. letošní start s Rocket Lab.
MAHIA, New Zealand, June 26, 2026 (GLOBE NEWSWIRE) -- Rocket Lab Corporation (Nasdaq: RKLB), a global leader in launch services and space systems, today announced it has successfully placed another satellite into orbit for Synspective, achieving a significant milestone as the tenth dedicated launch for the Japan-based Earth observation company with 100% mission success.
This latest launch - Rocket Lab’s 12th of the year - drives home the strength of one of the space industry's most enduring commercial partnerships while demonstrating Electron's unmatched reliability for dedicated small satellite missions.
The “Ten Owl Of Ten” mission launched on Electron from Launch Complex 1 in New Zealand at 5:43 a.m. NZST on June 27, 2026 to a 552km low Earth orbit. With this launch, Synspective's StriX constellation - which utilizes synthetic aperture radar (SAR) technology to capture detailed Earth imagery - now includes ten operational satellites, all of which have been deployed to space by Electron. Reflecting Rocket Lab’s customer-centric approach and commercial flexibility, a specially-configured Electron fairing was created for this mission to accommodate the StriX satellite’s specific dimensions: a key feature of Rocket Lab and Synspective’s partnership that has helped to ensure a 100% mission success rate across all StriX deployments.
This latest mission brings Rocket Lab’s overall launch tally to 91 missions, continuing to make Electron the world’s most frequently launched small-lift orbital rocket. Another 17 missions are booked for Synspective to complete the deployment of their constellation by the end of the decade. The next of those 17 upcoming missions is expected to launch in early Q3 this year.
Launch images and video: F91 | Ten Owl Of Ten | Flickr
About Rocket Lab
Rocket Lab is a leading space company that provides launch services, spacecraft, payloads and satellite components serving commercial, government, and national security markets. Rocket Lab’s Electron rocket is the world’s most frequently launched orbital small rocket; its HASTE rocket provides hypersonic test launch capability for the U.S. government and allied nations; and its Neutron launch vehicle in development will unlock medium launch for constellation deployment, national security and exploration missions. Rocket Lab’s spacecraft and satellite components have enabled more than 1,700 missions spanning commercial, defense and national security missions including GPS, constellations, and exploration missions to the Moon, Mars, and Venus. Rocket Lab is a publicly listed company on the Nasdaq stock exchange (RKLB). Learn more at www.rocketlabcorp.com.
Forward Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. We intend such forward-looking statements to be covered by the safe harbor provisions for forward looking statements contained in Section 27A of the Securities Act of 1933, as amended (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). All statements contained in this press release other than statements of historical fact, including, without limitation, statements regarding our launch and space systems operations, launch schedule and window, safe and repeatable access to space, Neutron development, operational expansion and business strategy are forward-looking statements. The words “believe,” “may,” “will,” “estimate,” “potential,” “continue,” “anticipate,” “intend,” “expect,” “strategy,” “future,” “could,” “would,” “project,” “plan,” “target,” and similar expressions are intended to identify forward-looking statements, though not all forward-looking statements use these words or expressions. These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including but not limited to the factors, risks and uncertainties included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2025, as such factors may be updated from time to time in our other filings with the Securities and Exchange Commission (the “SEC”), accessible on the SEC’s website at www.sec.gov and the Investor Relations section of our website at www.rocketlabcorp.com, which could cause our actual results to differ materially from those indicated by the forward-looking statements made in this press release. Any such forward-looking statements represent management’s estimates as of the date of this press release. While we may elect to update such forward-looking statements at some point in the future, we disclaim any obligation to do so, even if subsequent events cause our views to change.
Motorola Solutions rozšířila platformu Assist AI o nové funkce pro linku 911, včetně překladu v reálném čase, živého přenosu zvuku a shrnutí pomocí AI. Cílem je rychlejší reakce a lepší přehled pro záchranné týmy.
Key Takeaways MSI enhanced its Assist AI platform to improve 911 workflows and emergency response efficiency.MSI's Interpreter Agent detects the caller's language and enables real-time translation and transcription.MSI added live 911 audio, AI summaries and shared data to boost field situational awareness. Motorola Solutions, Inc. (MSI - Free Report) has enhanced its Assist AI agent platform with new features that enable faster response times and better situational awareness for emergency teams. The initiative strengthens the company’s AI capabilities within the 911 workflow, improving the efficiency of instant response operations.
Motorola introduced the Interpreter Agent to help overcome language barriers during 911 calls. The tool can detect a caller’s language in seconds and provide real-time two-way translation and live transcription. This helps dispatchers communicate faster and more clearly, reducing delays and improving communication during emergencies.
The company also added live 911 audio streaming, allowing first responders to access call audio directly in the field. Along with live conversations, the system provides AI-generated insights, including highlighted keywords, concise summaries and full call transcriptions through its dispatch software and mobile applications. This gives responders better real-time context and helps them take timely, more informed decisions before arriving at the scene.
In addition, real-time data is shared with operation centers, helping agencies coordinate resources more effectively and deploy specialized equipment, such as drones carrying medical supplies like EpiPens or automated external defibrillators, more quickly. With these capabilities, Motorola reduces information gaps across public safety workflows and supports better coordination during critical incidents.
How Are Competitors Performing in the Emergency Response Field?Motorola faces stiff competition from Nokia Corporation (NOK - Free Report) and Comtech Telecommunications Corp. (CMTL - Free Report) . Nokia is expanding its critical communication solutions to support faster emergency response. The company is using 5G and AI to improve communication and help first responders get real-time information. Nokia is strengthening its network solutions to improve response during emergencies and disasters.
Comtech is improving its communication technologies for quick mission-critical response. The company is helping emergency teams stay connected and share important information in real time. Comtech’s network solutions also support better coordination during urgent situations.
MSI’s Price Performance, Valuation & EstimatesMotorola shares have lost 5.2% over the past year against the industry’s growth of 40.6%.
Image Source: Zacks Investment Research
From a valuation standpoint, Motorola trades at a forward price-to-sales ratio of 5, below the industry tally of 5.02.
Image Source: Zacks Investment Research
Earnings estimates for 2026 have increased 1% to $16.96 over the past 60 days, while the same for 2027 have increased 0.8% to $18.42.
Image Source: Zacks Investment Research
Motorola currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Dick's Sporting Goods ve 1. fiskálním čtvrtletí zvýšil tržby o 62,7 % na 5,17 miliardy USD, ale upravený zisk na akcii 2,90 USD zaostal za odhady. Společnost zároveň potvrdila výhled tržeb na fiskální rok 2026 na 22,1–22,4 miliardy USD.
It has been about a month since the last earnings report for Dick's Sporting Goods (DKS - Free Report) . Shares have added about 4.9% in that time frame, outperforming the S&P 500.
But investors have to be wondering, will the recent positive trend continue leading up to its next earnings release, or is Dick's due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its latest earnings report in order to get a better handle on the important drivers.
DICK'S Sporting Q1 Earnings Miss Estimates, Comparable Sales Up 6%DICK'S Sporting posted first-quarter fiscal 2026 results, wherein the top line beat the Zacks Consensus Estimate and increased year over year. However, earnings missed the consensus mark and declined from the prior-year quarter.
The company delivered a strong fiscal first-quarter fiscal 2026 performance, with net sales rising sharply year over year and beating the Zacks Consensus Estimate, supported by continued momentum in the core DICK’S business and contributions from the Foot Locker acquisition. However, profitability was softer, as non-GAAP earnings declined from the prior-year quarter and missed estimates despite healthy comparable sales growth across the business.
The company reported adjusted earnings of $2.90 per share in the fiscal first quarter, lagging the Zacks Consensus Estimate of $2.91 and declining from $3.37 recorded in the year-ago quarter.
DKS’ Quarterly Performance: Key Metrics & InsightsNet sales of $5.17 billion increased 62.7% year over year and surpassed the consensus estimate of $5.06 billion. The upside was driven by the addition of the Foot Locker business, along with continued strength in the core DICK’S business. Consolidated comps for DICK'S Business grew 6% year over year, on growth in average ticket and transactions and broad-based momentum across footwear, apparel and hardlines.
Results reflected the inclusion of the Foot Locker business and the dilutive impact of shares issued for the acquisition, while core demand stayed healthy. Pro forma consolidated comparable sales increased 4.1% in the quarter.
DKS Records Higher Margins & ExpensesGross profit rose 44.5% year over year to $1.68 billion but the gross margin contracted 411 bps.
The SG&A expense rate of 22.5% fell 220 bps year over year. SG&A expenses, in dollar terms, grew almost 48.2% year over year to $1.16 billion.
DKS’ Financial Health SnapshotDICK’S Sporting ended the fiscal first quarter with cash and cash equivalents of $998.3 million. Inventories totaled $5.42 billion, up 52%, reflecting the addition of Foot Locker inventory, while long-term debt and financing lease obligations stood at $1.91 billion.
This Zacks Rank #3 (Hold) company repurchased 0.7 million shares under its share repurchase program for $141.2 million in the first quarter of fiscal 2026. It had $3 billion remaining under its authorization as of May 2, 2026. DKS also paid $5 million in fiscal 2025 for shares repurchased in the prior fiscal year.
On May 26, 2026, the company’s board of directors announced a quarterly cash dividend of $1.25 per share for holders of its common and Class B common stock. The dividend will be distributed on June 26 to its shareholders recorded as of the close of business on June 12.
What to Expect From DKS in FY26?For full-year fiscal 2026, the company expects net sales of $22.1-$22.4 billion. In its full-year fiscal 2026 segment outlook, the company expects net sales of $14.5-$14.7 billion for the DICK’S business and $7.6-$7.7 billion for the Foot Locker business. Operating income guidance was updated to $1.69-$1.81 billion on a GAAP basis and $1.71-$1.83 billion on a non-GAAP basis, while GAAP earnings are projected at $13.27-$14.27 per diluted share; non-GAAP earnings are still expected at $13.50-$14.50. The company expects planned gross capital spending of about $1.6 billion for fiscal 2026.
At the segment level, DKS raised the low end of its comparable sales outlook to 2.5%-4.0%, while the Foot Locker business raised the low end of its pro forma comparable sales view to 1.5%-3.0%. Management also outlined segment profit expectations of $1.60-$1.68 billion for the DICK’S business and $110-$150 million for Foot Locker.
How Have Estimates Been Moving Since Then?In the past month, investors have witnessed a downward trend in fresh estimates.
VGM ScoresCurrently, Dick's has a average Growth Score of C, though it is lagging a lot on the Momentum Score front with an F. However, the stock has a score of C on the value side, putting it in the middle 20% for this investment strategy.
Overall, the stock has an aggregate VGM Score of C. If you aren't focused on one strategy, this score is the one you should be interested in.
OutlookEstimates have been broadly trending downward for the stock, and the magnitude of these revisions indicates a downward shift. Notably, Dick's has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.
HEICO za 2. čtvrtletí fiskálního roku 2026 překonal odhady: EPS činil 1,66 USD a tržby vzrostly na 1,38 miliardy USD. Čistý zisk připadající akcionářům dosáhl rekordních 233,8 milionu USD.
A month has gone by since the last earnings report for Heico Corporation (HEI - Free Report) . Shares have lost about 0.8% in that time frame, outperforming the S&P 500.
Will the recent negative trend continue leading up to its next earnings release, or is Heico due for a breakout? Well, first let's take a quick look at its most recent earnings report in order to get a better handle on the recent catalysts for Heico Corporation before we dive into how investors and analysts have reacted as of late.
HEICO Q2 Earnings Beat Estimates, Sales Increase Year Over Year
HEICO Corporation posted second-quarter fiscal 2026 earnings of $1.66 per share, which beat the Zacks Consensus Estimate of $1.33 by 24.6%. The bottom line also improved 48.2% from the year-ago quarter’s $1.12.
HEI’s Total SalesQuarterly net sales came in at $1.38 billion, up 25.3% year over year and 10.7% above the consensus mark of $1.24 billion. Results were driven by consolidated organic net sales growth of 18% and contributions from acquisitions.
HEICO’s Operational UpdateHEICO’s cost of sales increased 22.1% year over year to $806.2 million.
The company’s selling, general and administrative (SG&A) expenses rose 15.5% to $219.1 million.
Interest expense climbed 3.9% to $34.2 million from $32.9 million in the year-ago quarter.
HEI Posts Record Profit as Margins ExpandOperating income rose 41.2% year over year to $350.4 million, and consolidated operating margin expanded to 25.5% from 22.6% in the prior-year period.
HEI delivered record quarterly net income attributable of $233.8 million, up 49% year over year.
HEI’s Segmental Performance in Q2Flight Support Group: Net sales from this segment rose 21% year over year to $929.4 million. Growth was led by robust organic expansion of 19%, supported by improved demand across the group’s product lines as well as the impact of fiscal 2026 acquisitions.
The segment’s operating income increased 31% year over year to $243.1 million, and operating margin improved to 26.2% from 24.1%, helped by a more favorable product mix and efficiencies in SG&A expenses.
Electronic Technologies Group: The segment’s net sales climbed 34% to $459.5 million. The increase reflected organic growth of 17% plus contributions from acquisitions completed in fiscal 2025 and fiscal 2026, with demand improving across several end markets.
The segment’s operating income rose 56% year over year to $121.8 million, and operating margin expanded to 26.5% from 22.8%, driven by net sales growth, improved gross profit margin and better SG&A leverage.
HEI’s Financial DetailsAs of April 30, 2026, HEI’s cash and cash equivalents totaled $210.3 million compared with $217.8 million as of Oct. 31, 2025.
Cash flow provided by operating activities was $470.6 million during the first six months of fiscal 2026, reflecting a rise of 15.4% from the prior-year period’s level.
HEICO reported a long-term debt (net of current maturities) of $2.58 billion as of April 30, 2026, up from $2.16 billion as of Oct. 31, 2025.
How Have Estimates Been Moving Since Then?In the past month, investors have witnessed a upward trend in fresh estimates.
VGM ScoresAt this time, Heico has a average Growth Score of C, though it is lagging a lot on the Momentum Score front with an F. Following the exact same course, the stock was allocated a grade of F on the value side, putting it in the fifth quintile for value investors.
Overall, the stock has an aggregate VGM Score of F. If you aren't focused on one strategy, this score is the one you should be interested in.
OutlookEstimates have been trending upward for the stock, and the magnitude of these revisions looks promising. It comes with little surprise Heico has a Zacks Rank #1 (Strong Buy). We expect an above average return from the stock in the next few months.
Digital media platform Rumble Inc. (RUM 0.24%), known for video sharing and livestreaming, just recorded a notable insider buy amid ongoing sector competition.
Tether Global Investments Fund reported an open-market acquisition of 4,599,365 shares for a transaction value of approximately $36.2 million, as disclosed in the SEC Form 4 filing.
Transaction summaryMetricValueShares traded4,599,365Transaction value$36.2 millionPost-transaction shares (direct)0Post-transaction shares (indirect)141,877,369Post-transaction value (direct ownership)~$0Transaction value based on SEC Form 4 weighted average purchase price ($7.88); post-transaction value based on June 17, 2026 SEC Form 4 reported position value ($0.00).
Key questionsWhat structure or mechanism governed the acquisition of Rumble shares in this transaction?
This acquisition was conducted through the exercise of derivative securities, specifically pre-funded warrants, by Tether Investments, S.A. de C.V, a wholly owned subsidiary of Tether Global Investments Fund, S.I.C.A.F. S.A, with all shares held indirectly post-transaction.How did this transaction affect the insider's overall ownership and stake in Rumble?
The transaction resulted in indirect Class A holdings of 141,877,369 shares after completion, while direct ownership remained unchanged at zero.What is the significance of the remaining pre-funded warrants and indirect holdings for future equity exposure?
With 154,408,073 pre-funded warrants still outstanding (all indirect), Tether Global Investments Fund, S.I.C.A.F. S.A. retains the capacity to further increase its Class A Common Stock exposure in line with voting limitations and capital allocation strategy.How does the transaction size compare to previous activity, and does it signal a change in cadence?
While the 4.6 million shares acquired are higher than the only other previously reported transaction (777,012 shares in February 2026), the overall cadence remains episodic, with only two acquisition events disclosed since February of this year, likely reflecting transaction-specific capacity constraints and contractual considerations rather than a trend shift.Company overviewMetricValuePrice (as of market close 2026-06-17)$7.88Market capitalization$2.71 billionRevenue (TTM)$102.38 millionNet income (TTM)-$109.45 million* 1-year performance is calculated using June 17th, 2026 as the reference date.
Company snapshotOffers a video sharing platform, livestreaming and monetization tools, an in-house advertising marketplace, and a crypto wallet; generates revenue from advertising, subscriptions, pay-per-view, and tipping services.Operates a multi-sided platform business model, monetizing both content creators and advertisers through digital media distribution and cloud infrastructure services.Serves content creators, media organizations, and audiences seeking alternative video platforms in the United States, Canada, and international markets.Rumble Inc. is a digital media and cloud services company specializing in video sharing, livestreaming, and advertising solutions. The company leverages a proprietary platform to enable content creators to reach audiences and monetize their work through multiple channels. Its integrated cloud and advertising offerings position it as a competitive alternative in the online video and digital infrastructure space.
What this transaction means for investorsThether continues to show faith in streaming platform Rumble by converting more of its warrants into shares. Tether’s buying habits over the past year have acted as a backstop for Rumble shares, with the El Salvador-based crypto business buying at what have turned out to be near-term lows.
This time, however, Tether hasn’t had time to see a bearish move play out, with shares continuing to slip after this reported purchase. That timing likely matters little to Tether, which has amassed a diverse portfolio of crypto, gold, and equity in multiple companies, worth at least $10 billion.
While it isn’t perfectly clear how a streaming business fits in with a primarily crypto-focused outlet, the two businesses have affinities among management that suggest Tether is a long-term investor in Rumble. Rumble management, for its part, sees Tether’s other portfolio companies as natural customers of its products.
For those considering an investment in Rumble, take the latest share buy as a sign that Tether will continue to support the business and its shares for the foreseeable future.
Brendan Coffey has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.
Společnost Dycom Industries zvýšila výhled pro fiskální rok 2027 po silném prvním čtvrtletí, kdy tržby i upravený EPS překonaly odhady. Akcie za měsíc klesly asi o 7,8 %.
A month has gone by since the last earnings report for Dycom Industries (DY - Free Report) . Shares have lost about 7.8% in that time frame, underperforming the S&P 500.
Will the recent negative trend continue leading up to its next earnings release, or is Dycom Industries due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important drivers.
Dycom Q1 Earnings & Revenues Top, Raises FY2027 OutlookDycom Industries reported stellar results for the first quarter of fiscal 2027 (ended May 2, 2026). Adjusted earnings and contract revenues surpassed the Zacks Consensus Estimate and grew year over year.
Q1 Earnings & Revenue DiscussionDycom reported adjusted earnings per share (EPS) of $4.42, which topped the Zacks Consensus Estimate of $2.73 by 61.9%. In the year-ago quarter, it reported an adjusted EPS of $2.39.
Contract revenues of $1.96 billion surpassed the consensus mark of $1.67 billion by 18.0% and grew 56.1% year over year. The metric rose 24.7% on an organic basis.
Management noted that demand for fiber infrastructure deployments and data center builds remained robust during the quarter. Power Solutions also outperformed in its first full quarter as part of the Building Systems segment.
Operations & Backlog DetailsAdjusted EBITDA increased 74.6% to $262.5 million from a year ago. Adjusted EBITDA margin of 13.4% expanded 141 basis points (bps) from the year-ago level.
Dycom’s backlog as of the first fiscal quarter totaled $11.91 billion, up 46.5% year over year from $8.13 billion. Of the current backlog position, $6.40 billion is projected to be completed in the next 12 months.
Segmental DetailsBeginning in the fourth quarter of fiscal 2026, Dycom reports results through two reportable segments: Communications and Building Systems.
Communications: This segment’s contract revenues increased 24.7% year over year to $1.57 billion. Growth was driven by expansion into additional geographies and fiber-to-the-home builds that ramped ahead of expectations, supported by favorable seasonal conditions. Adjusted EBITDA increased to $192.4 million from $150.4 million a year ago. Adjusted EBITDA margin of 12.3% expanded 31 bps from the year-ago level. This segment’s total backlog grew to $10.80 billion from $8.13 billion a year ago, with a 12-month backlog of $5.38 billion.
Building Systems: The segment generated contract revenues of $395.4 million. Adjusted EBITDA was $70.0 million and adjusted EBITDA margin was 17.7%. Total backlog stood at $1.11 billion, with a 12-month backlog of $1.02 billion. The segment benefited from strong execution and demand that exceeded initial expectations.
Balance Sheet & Cash FlowAs of May 2, 2026, Dycom had cash and cash equivalents of $538.8 million compared with $709.2 million as of fiscal 2026-end. Long-term debt was $2.81 billion, relatively unchanged from $2.81 billion at fiscal 2026-end.
During the first fiscal quarter, DY repurchased 100,000 shares for $36 million.
Q2 GuidanceDycom expects contract revenues between $1.94 billion and $2.01 billion for the second quarter of fiscal 2027. Adjusted EBITDA is expected to be between $284 million and $303 million. The company anticipates adjusted EPS in the range of $4.40-$4.82.
Fiscal 2027 ViewBased on strong fiscal first-quarter results and expectations for the remainder of the year, Dycom raised its fiscal 2027 outlook. The company now expects contract revenues between $7.38 billion and $7.65 billion, up from its prior guided range of $6.85 billion to $7.15 billion. The updated outlook implies a 33.1-37.9% year-over-year rise and 12.6-15.8% organic growth.
The company continues to anticipate adjusted EBITDA margin expansion in fiscal 2027. In the Communications segment, Dycom expects modest adjusted EBITDA margin improvement as operating leverage offsets continued investment to support growth. In the Building Systems segment, the company now expects adjusted EBITDA margin in the high teens, an improvement from its earlier expectation of a mid-teen margin.
For fiscal 2027, Dycom expects Communications segment revenues between $6.03 billion and $6.20 billion, while Building Systems revenues are projected between $1.35 billion and $1.45 billion.
How Have Estimates Been Moving Since Then?Since the earnings release, investors have witnessed a upward trend in fresh estimates.
The consensus estimate has shifted 16.49% due to these changes.
VGM ScoresCurrently, Dycom Industries has a strong Growth Score of A, though it is lagging a lot on the Momentum Score front with a C. Charting a somewhat similar path, the stock has a score of D on the value side, putting it in the bottom 40% for value investors.
Overall, the stock has an aggregate VGM Score of B. If you aren't focused on one strategy, this score is the one you should be interested in.
OutlookEstimates have been trending upward for the stock, and the magnitude of these revisions looks promising. It comes with little surprise Dycom Industries has a Zacks Rank #1 (Strong Buy). We expect an above average return from the stock in the next few months.
The Ensign Group čelí vyšetřování kvůli možným porušením federálních zákonů o cenných papírech po obviněních ze zkreslování kvality péče a podvodného vykazování.
NEW YORK, June 26, 2026 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating The Ensign Group (NASDAQ: ENSG) (“Ensign” or the “Company”) for potential violations of the federal securities laws.
On June 8, 2026, Hunterbrook published a detailed short-seller report alleging that the company engaged in systemic quality-measure gaming, falsified care-quality data, and improper related-party billing across its skilled nursing operations. Following this news, the price of Ensign stock fell significantly, causing millions of dollars in shareholder losses.
Then, on June 11, 2026, Muddy Waters Research published a short report on Ensign Group, alleging possible Medicare and Medicaid fraud via a scheme to rent licenses of administrators of skilled nursing facilities who are not actually managing the facilities, potentially in violation of the False Claims Act. This news caused the price of Ensign stock to drop even further.
“Our investigation concerns whether the company and its executives provided investors with accurate and complete information about the company,” said Andrea Farah, Lowey Dannenberg, P.C., Partner and Head of the firm’s securities practice.
If you suffered a loss in Ensign securities and wish to participate, check your eligibility through Lowey’s case management platform, https://claimmagic.com/cases/the-ensign-group. Alternatively, you can contact our attorneys Andrea Farah ([email protected]) at (914)733-7256 or Vincent R. Cappucci Jr. ([email protected]) at (914)733-7278.
About Lowey Dannenberg
Lowey Dannenberg is a national firm representing institutional and individual investors who suffered financial losses resulting from corporate fraud and malfeasance in violation of federal securities and antitrust laws. The firm has significant experience in prosecuting multi-million-dollar lawsuits and has previously recovered billions of dollars on behalf of investors.
Attorney Advertising
Contact
Lowey Dannenberg P.C.
44 South Broadway, Suite 1100
White Plains, NY 10601
Tel: (914) 733-7256
Email: [email protected]
